Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036185	maksa-2-is	u/l (u/l)	862	974	0.00%
3036185	afosmaksa2	u/l (u/l)	497	557	0.18%
3036185	s-afmaks2	u/l (—)	164	184	100.00%	Distribution not available
3036185	afosmaksa2	— (—)	138	145	100.00%	Distribution not available
3036185	s-maksa-2	u/l (u/l)	99	110	0.00%
3036185	s-maksa2	u/l (u/l)	67	68	0.00%
3036185	s-afos2ma	u/l (—)	66	75	100.00%	Distribution not available
3036185	afosmaks2	u/l (—)	56	68	100.00%	Distribution not available
3036185	maksa-2-is	— (—)	55	62	100.00%	Distribution not available
3036185	s-maksa-2-isoentsyymi	u/l (u/l)	22	22	0.00%	Distribution not available
3036185	maksa-2-ls	u/l (u/l)	18	22	0.00%
3036185	maksa-2-isoentsyymi	u/l (u/l)	14	14	0.00%
3036185	s-maksa-2	— (—)	12	12	100.00%	Distribution not available
3036185	s-maksa2	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

314

500

6.27

182.65

1.2

1.1

34.43

25.50

u/l

1.14

299

430

Diseases of liver

338

652

5.27

164.98

1.2

1.1

34.69

24.74

u/l

1.71

302

592

Renal failure

384

734

4.68

157.19

1.2

1.1

37.86

26.20

u/l

1.84

364

636

All chronic kidney diseases

420

801

4.33

152.41

1.2

1.1

33.84

21.80

u/l

2.36

396

695

ILD medications: immunosuppressive drugs

439

1094

3.76

137.28

1.2

1.1

24.82

21.77

u/l

0.41

419

969

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

604

1343

3.12

130.40

1.2

1.1

34.42

19.88

u/l

4.34

557

1201

Anaemias

179

113

10.46

127.83

1.2

38.01

10.31

u/l

3.28

167

105

Other diseases of liver

206

328

6.42

123.41

1.2

1.1

30.88

24.14

u/l

0.86

182

298

Renal tubulo-interstitial diseases

549

1319

3.12

121.23

1.2

1.1

35.54

19.71

u/l

5.11

513

1171

Abnormal findings on examination of blood, without diagnosis

349

802

4.04

120.04

1.2

1.1

28.38

26.34

u/l

0.24

328

706

Any gastric operation

383

433

4.46

118.70

1.2

1.1

24.08

15.78

u/l

1.78

355

369

GASTRO-related operations

383

433

4.46

118.70

1.2

1.1

24.08

15.78

u/l

1.78

355

369

Autoimmune diseases excluding thyroid diseases

576

1003

3.15

116.89

1.1

25.10

22.16

u/l

0.45

536

900

Autoimmune diseases excluding thyroid diseases, strict definition

561

965

3.20

116.84

1.1

23.61

22.53

u/l

0.17

521

866

All kidney diseases

569

1344

2.91

109.00

1.2

1.1

32.91

19.26

u/l

4.36

535

1193

Other bacterial diseases

557

1300

2.90

105.38

1.2

1.1

36.18

19.35

u/l

5.77

516

1161

First line medication for Crohn's disease

592

1111

2.89

104.33

1.2

1.1

27.20

21.64

u/l

1.06

561

974

Autoimmune diseases related-to ILD

496

1492

2.86

98.02

1.1

23.52

24.21

u/l

0.07

463

1334

Autoimmune diseases

564

1015

2.84

94.27

1.1

26.68

22.02

u/l

0.73

512

912

ILD medications

592

1188

2.71

93.36

1.1

27.56

21.74

u/l

1.16

557

1048

ILD medications: prednisolone, methylprednisolone, prednisone

577

1185

2.74

93.31

1.1

29.06

21.77

u/l

1.57

547

1046

Other bacterial diseases

550

1305

2.69

89.44

1.2

1.1

34.76

18.92

u/l

5.33

510

1170

Bacterial infection, other or unspecified

339

893

3.32

86.56

1.2

1.1

42.56

20.13

u/l

4.70

313

786

Abnormal serum enzyme levels

226

517

4.31

86.44

1.2

1.1

28.98

30.74

u/l

0.14

215

458

Fever of other and unknown origin

340

927

3.29

86.14

1.2

1.1

40.86

20.85

u/l

3.65

324

834

Used for control exclusion in common control thyroid runs

511

913

2.84

85.37

1.1

26.66

22.15

u/l

0.63

467

823

Bacterial infection, other or unspecified

352

951

3.15

82.14

1.2

1.1

41.81

19.92

u/l

4.79

324

840

Other septicaemia

256

656

3.79

81.97

1.2

1.1

36.37

22.23

u/l

2.49

241

572

Insulin, fast-acting

242

641

3.81

78.96

1.2

1.1

40.21

23.10

u/l

2.15

221

573

Septicaemia

271

717

3.57

78.87

1.2

1.1

35.67

21.30

u/l

2.80

255

628

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

510

1284

2.60

78.43

1.2

1.1

25.00

23.17

u/l

0.30

461

1160

Inflammatory bowel disease treatment related agents

579

1311

2.48

77.67

1.1

27.34

22.38

u/l

0.91

543

1165

Fibrosis and cirrhosis of liver

102

125

8.41

77.57

1.1

36.95

22.66

u/l

1.89

115

Heart failure, not strict

431

1055

2.79

76.75

1.2

1.1

35.21

21.51

u/l

3.22

395

944

Insulin, fast-acting or short human

242

660

3.70

75.70

1.2

1.1

40.21

24.14

u/l

1.94

221

592

Acute renal failure

166

344

4.89

74.83

1.2

1.1

48.98

26.51

u/l

2.14

156

304

Explicit Sepsis

278

779

3.36

73.84

1.2

1.1

35.19

23.23

u/l

2.11

262

685

Aplastic and other anaemias

295

857

3.24

73.71

1.1

38.53

24.60

u/l

2.08

272

747

Bacterial Sepsis

290

761

3.28

72.53

1.2

1.1

41.68

23.62

u/l

2.73

265

662

Implicit Sepsis

412

1151

2.71

71.79

1.1

35.36

21.77

u/l

2.80

372

1024

Oral corticosteroids

536

1300

2.46

71.77

1.1

28.71

22.47

u/l

1.16

500

1154

Diabetic nephropathy, excluding more controls

148

223

5.57

71.52

1.2

1.1

41.68

27.65

u/l

1.03

141

198

Disorders of gallbladder, biliary tract and pancreas

526

1361

2.45

71.12

1.2

1.1

28.36

22.40

u/l

1.12

473

1232

Implicit bacterial Sepsis

263

687

3.42

70.91

1.2

1.1

44.62

24.89

u/l

2.68

238

595

Nonalcoholic fatty liver disease

108

159

6.95

69.92

1.2

1.1

25.19

20.60

u/l

0.57

149

Type 1 diabetes, wide definition, subgroup 1

148

297

5.03

69.15

1.2

1.1

40.92

20.39

u/l

1.80

134

274

Implicit bacterial Sepsis

277

742

3.25

68.40

1.2

1.1

43.39

23.87

u/l

2.86

250

644

L04AD Calcineurin inhibitors

112

176

6.50

68.13

1.3

1.1

30.31

23.46

u/l

0.59

107

165

Diabetic nephropathy

148

304

4.90

66.27

1.2

1.1

41.68

34.03

u/l

0.42

141

270

Persons encountering health services in other circumstances

240

707

3.40

66.25

1.1

29.19

24.27

u/l

0.36

215

626

Malignant neoplasm of breast, HER-positive

245

553

3.49

65.53

1.2

1.1

16.95

19.41

u/l

0.40

233

481

Malignant neoplasm of breast, HER2-negative

294

605

3.21

65.48

1.2

1.1

17.00

18.91

u/l

0.32

273

529

Osteopathies and chondropathies

332

1111

2.80

64.69

1.2

1.1

32.72

23.76

u/l

1.18

302

1000

Malignant neoplasm of breast

294

610

3.17

64.26

1.2

1.1

17.00

18.80

u/l

0.30

273

534

Disorders of other endocrine glands

268

852

3.12

63.94

1.2

1.1

30.04

23.66

u/l

0.56

246

769

Type 1 diabetes

164

382

4.33

63.81

1.2

1.1

38.60

21.72

u/l

1.49

149

348

Disorders of parathyroid gland

174

419

4.16

63.78

1.2

1.1

29.68

23.30

u/l

0.37

163

366

Malignant neoplasm of breast, ER-positive, including Hilmo

245

559

3.42

63.23

1.2

1.1

16.95

19.34

u/l

0.38

233

486

Malignant neoplasm of breast, HER2-negative, including Hilmo

296

618

3.13

63.15

1.2

1.1

16.33

18.65

u/l

0.43

275

542

Malignant neoplasm of breast, including Hilmo

296

618

3.13

63.14

1.2

1.1

16.33

18.65

u/l

0.43

275

542

Type 1 diabetes, wide definition

149

326

4.61

62.80

1.2

1.1

41.45

19.99

u/l

1.96

135

300

L04AA Selective immunosuppressants

169

409

4.18

62.75

1.2

1.1

24.82

23.12

u/l

0.18

162

367

Insulin, intermediate and long-acting

308

1057

2.85

62.56

1.2

1.1

38.81

22.73

u/l

2.71

279

944

Insulin medication

335

1026

2.76

62.12

1.2

1.1

39.43

21.06

u/l

3.77

305

916

Insulin, combination of fast acting with intermediate-acting or long-acting

335

1128

2.73

61.93

1.2

1.1

39.43

22.37

u/l

3.31

305

1006

Second line medication for Crohn's disease

328

1226

2.69

60.16

1.2

1.1

22.72

23.91

u/l

0.11

313

1096

Malignant neoplasm

426

1015

2.49

58.95

1.2

1.1

29.12

21.87

u/l

1.16

401

895

Implicit Sepsis

417

1251

2.45

58.74

1.1

34.85

21.49

u/l

2.81

376

1118

Persons encountering health services for specific procedures and health care

514

1362

2.27

58.34

1.2

1.1

31.89

19.94

u/l

3.12

475

1222

L02BG Aromatase inhibitors

221

683

3.27

57.08

1.2

1.1

17.36

23.44

u/l

1.15

211

604

Hyperparathyroidism

154

369

4.18

56.96

1.2

1.1

26.90

23.69

u/l

0.17

144

325

Diabetic maculopathy, excluding more controls

152

6.35

56.77

1.3

1.1

32.45

25.04

u/l

0.50

139

IBD patients in KELA-register

152

367

4.18

56.62

1.1

20.62

25.17

u/l

0.25

145

331

Osteoporosis

192

505

3.59

56.57

1.1

31.32

23.98

u/l

0.60

175

443

Hernia of abdominal wall, postoperative

164

6.03

55.88

1.2

1.1

33.11

18.21

u/l

0.78

131

Presence of other functional implants

326

840

2.71

55.44

1.2

1.1

25.46

26.37

u/l

0.10

283

753

Noninfective enteritis and colitis

263

919

2.88

54.80

1.1

21.57

24.20

u/l

0.20

250

821

Malignant neoplasm, wide definition for exclusion

422

1029

2.42

54.54

1.2

1.1

28.02

21.69

u/l

0.98

397

909

Reimbursement for rheumatic diseases

322

1249

2.58

54.41

1.1

22.74

25.26

u/l

0.42

296

1119

Other anaemias

254

828

2.94

54.30

1.1

40.71

25.03

u/l

2.06

235

721

Polyarthropathies

358

915

2.57

54.12

1.2

1.1

31.34

23.49

u/l

0.99

329

825

Other and unspecified anaemias

252

826

2.93

53.63

1.1

40.84

25.08

u/l

2.06

234

719

Condition for Implicit Sepsis (Organ dysfunction codes)

422

1277

2.34

53.63

1.1

34.72

21.51

u/l

2.83

383

1141

Solid cancers, helper endpoint

409

1006

2.41

52.79

1.2

1.1

27.19

22.02

u/l

0.72

384

886

Inflammatory bowel disease, strict (require KELA)

152

389

3.95

52.35

1.1

20.62

24.89

u/l

0.23

145

351

Medicines for HER+ breast cancer

246

803

2.93

52.22

1.2

1.1

16.90

23.43

u/l

1.50

234

711

L04AX Other immunosuppressants

309

1204

2.58

52.21

1.2

1.1

22.94

23.75

u/l

0.07

295

1078

Any reimbursement code in KELA

213

296

3.62

51.65

1.2

1.1

20.54

16.24

u/l

0.67

198

268

Abnormal results of function studies

141

6.29

51.41

1.2

1.1

31.34

24.10

u/l

0.46

128

Inflammatory bowel disease

191

577

3.34

51.32

1.1

20.69

23.80

u/l

0.20

182

522

Any event in cancer register

427

1085

2.33

51.02

1.1

28.24

21.93

u/l

0.99

398

965

Metabolic disorders

463

1270

2.23

50.87

1.2

1.1

31.23

20.69

u/l

2.32

420

1145

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

349

1294

2.43

50.60

1.2

1.1

30.83

24.53

u/l

1.06

324

1149

Oxycodone

230

701

2.99

50.18

1.2

1.1

40.66

21.68

u/l

3.67

213

625

Sub-endpoint used in defining T1D endpoints

172

486

3.51

49.80

1.2

1.1

40.70

23.20

u/l

1.69

155

443

Diseases of oesophagus, stomach and duodenum

496

1387

2.15

49.30

1.1

26.88

22.90

u/l

0.59

453

1255

Persons encountering health services for other counselling and medical advice, not elsewhere classified

502

1270

2.16

49.15

1.2

1.1

24.32

23.47

u/l

0.10

475

1123

5-aminosalicylic acid

133

325

4.13

48.81

1.1

22.79

22.36

u/l

0.02

124

285

Persons encountering health services in other circumstances, wide

523

1277

2.12

48.16

1.2

1.1

25.58

23.51

u/l

0.26

489

1129

Cholangitis (primary sclerosing, PSC)

7.65

48.03

1.2

1.1

36.10

28.27

u/l

0.48

Oedema, not elsewhere classified

191

597

3.18

47.34

1.2

1.1

30.09

21.41

u/l

0.87

174

535

Heart failure and antihypertensive medication

151

245

4.07

47.20

1.2

1.1

47.23

22.41

u/l

2.41

137

219

Condition for Implicit Sepsis (Organ dysfunction codes)

417

1302

2.22

46.49

1.1

34.98

21.00

u/l

3.00

377

1167

Complications of surgical and medical care, not elsewhere classified

467

1527

2.10

45.59

1.2

1.1

28.55

23.07

u/l

1.05

434

1366

Influenza and pneumonia

473

1443

2.09

44.79

1.2

1.1

29.50

21.18

u/l

2.56

433

1302

Diabetic retinopathy, strict definition

136

311

3.92

44.60

1.2

1.1

43.01

33.85

u/l

0.48

121

284

Pneumonia, organism unspecified

423

1377

2.16

44.56

1.2

1.1

30.60

21.77

u/l

2.37

387

1239

Ulcerative colitis

146

412

3.57

43.71

1.2

1.1

22.17

24.45

u/l

0.11

139

373

Cholelithiasis, broad definition with cholecystitis

413

1284

2.17

43.69

1.1

23.40

22.83

u/l

0.09

371

1157

Other disorders of fluid, electrolyte and acid-base balance

186

581

3.07

43.17

1.2

1.1

33.62

23.15

u/l

1.59

175

510

Acute tubulo-interstitial nephritis

300

1079

2.41

42.69

1.2

1.1

28.25

20.47

u/l

1.83

275

954

Pneumonias (Asthma/COPD co-morbidities)

453

1471

2.07

42.60

1.2

1.1

29.55

21.77

u/l

2.13

417

1325

All pneumoniae

454

1477

2.06

41.94

1.2

1.1

30.48

21.41

u/l

2.63

417

1331

General symptoms and signs

455

1085

2.11

41.31

1.1

31.61

20.59

u/l

1.94

410

979

Ulcer of lower limb, not elsewhere classified

105

244

4.36

41.30

1.2

1.1

52.60

31.66

u/l

1.13

220

Hypertensive diseases (excluding secondary)

249

533

2.73

40.95

1.2

1.1

20.70

15.33

u/l

0.90

228

488

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

114

285

4.04

40.67

1.2

1.1

13.34

25.57

u/l

3.23

109

263

Hypertension, essential

360

899

2.28

40.64

1.2

1.1

27.27

19.24

u/l

1.14

327

819

Hypertensive diseases

364

911

2.26

40.60

1.2

1.1

23.38

19.65

u/l

0.68

330

830

Hypertension

364

911

2.26

40.58

1.2

1.1

23.38

19.65

u/l

0.68

330

830

Ulcerative colitis (strict definition, require KELA)

107

258

4.19

40.09

1.2

1.1

13.28

26.58

u/l

3.28

102

240

Insulin, fast-acting (human)

183

4.86

39.67

1.3

1.1

44.13

20.26

u/l

1.32

170

Heart failure,strict

254

700

2.57

39.56

1.1

40.59

23.34

u/l

2.56

228

612

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

104

251

4.19

38.93

1.2

1.1

13.04

26.64

u/l

3.31

235

Certain infectious and parasitic diseases

415

980

2.13

38.62

1.2

1.1

29.80

19.69

u/l

2.10

380

879

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

438

1484

2.02

38.55

1.2

1.1

29.95

22.09

u/l

2.09

403

1334

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

408

1183

2.10

38.47

1.2

1.1

28.46

22.63

u/l

1.27

374

1067

408

1183

2.10

38.47

1.2

1.1

28.46

22.63

u/l

1.27

374

1067

Crohn disease

178

4.83

38.04

1.1

28.15

22.84

u/l

0.16

165

Hypothyroidism, levothyroxine purchases

101

115

4.99

37.71

1.2

41.04

10.20

u/l

1.43

107

Hypothyroidism and >3 levothyroxin purchases

101

115

4.99

37.71

1.2

41.04

10.20

u/l

1.43

107

Cholelithiasis

385

1269

2.10

37.65

1.2

1.1

19.61

22.82

u/l

0.92

346

1143

Nutritional anaemias

257

1033

2.41

37.51

1.2

1.1

38.34

23.36

u/l

1.51

236

915

Hypothyroidism (congenital or acquired)

101

116

4.94

37.33

1.2

41.04

10.15

u/l

1.43

108

Other disorders of skin and subcutaneous tissue, not elsewhere classified

101

247

4.14

37.19

1.2

1.1

34.27

25.51

u/l

0.68

219

Implicit viral Sepsis

157

514

3.08

37.05

1.2

1.1

39.94

23.74

u/l

1.68

147

451

Liquid cancers, helper endpoint

186

580

2.81

36.31

1.1

41.59

21.95

u/l

2.01

175

503

Gastro-oesophageal reflux disease

323

1287

2.17

36.26

1.1

24.55

23.79

u/l

0.07

296

1158

Other disorders of skin and subcutaneous tissue

339

1423

2.13

36.14

1.2

1.1

32.51

23.23

u/l

1.62

313

1271

Finngen Rheumatological endpoints

403

1118

2.06

35.71

1.1

28.30

21.65

u/l

0.93

374

1012

Other diseases of blood and blood-forming organs, wide

136

420

3.27

35.48

1.2

1.1

34.53

25.90

u/l

0.79

126

373

Gout

148

417

3.15

35.19

1.1

41.28

27.38

u/l

0.96

133

363

Hypothyroidism, strict autoimmune

297

866

2.26

34.62

1.2

1.1

23.83

22.48

u/l

0.14

261

779

General examination and investigation of persons without complaint and reported diagnosis

282

622

2.37

34.27

1.1

24.84

22.43

u/l

0.21

266

550

Other retinal disorders

307

1107

2.17

33.62

1.2

1.1

33.69

24.46

u/l

1.26

275

986

Diabetes mellitus

442

1338

1.94

33.49

1.1

32.58

19.78

u/l

3.08

398

1212

Nausea and vomiting

143

460

3.07

33.47

1.2

1.1

41.94

24.81

u/l

1.42

132

416

Complications of medical and surgical care

344

1554

2.04

33.30

1.1

30.44

23.08

u/l

1.14

325

1384

Iron deficiency anaemia

217

875

2.46

33.24

1.1

40.09

24.37

u/l

1.28

200

780

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

418

1286

1.96

33.23

1.1

33.39

20.24

u/l

3.04

373

1162

Diabetes, varying definitions

440

1338

1.93

33.22

1.1

32.70

19.75

u/l

3.13

397

1211

Gout, FINNGEN

148

498

2.98

33.19

1.1

41.28

28.52

u/l

0.85

133

436

Caries of dentine

125

370

3.31

33.17

1.2

1.1

33.94

28.74

u/l

0.29

118

335

Erysipelas

311

1110

2.15

33.05

1.1

30.67

20.32

u/l

1.95

284

988

Heart failure, strict

272

854

2.26

32.04

1.1

40.32

24.50

u/l

2.44

242

752

Osteoporosis with pathological fracture (FG)

122

5.34

32.02

1.2

1.1

39.27

28.16

u/l

0.35

105

Primary hyperparathyroidism

227

4.03

31.90

1.2

1.1

30.89

22.09

u/l

0.30

204

Diabetic maculopathy

224

3.97

31.77

1.3

1.1

32.56

37.60

u/l

0.24

203

Type 2 diabetes, wide definition

362

1150

2.02

31.65

1.1

37.62

20.49

u/l

3.79

329

1036

All-cause Heart Failure

268

843

2.25

31.52

1.1

40.53

24.71

u/l

2.38

238

743

Dermatitis and eczema

465

1562

1.85

31.22

1.2

1.1

23.72

24.12

u/l

0.05

428

1403

Hypothyroidism, drug reimbursement

5.53

30.71

1.2

28.59

11.36

u/l

0.89

Dental caries

131

417

3.04

30.15

1.2

1.1

33.28

28.90

u/l

0.25

124

378

Diseases of the skin and subcutaneous tissue

401

1032

1.95

30.05

1.1

25.50

22.89

u/l

0.34

369

918

Disorders of thyroid, IBD co-morbidities

153

4.16

29.98

1.2

1.1

19.20

13.95

u/l

0.51

137

Diabetes, insulin treatment (Kela reimbursement)

435

1410

1.87

29.97

1.1

32.99

21.02

u/l

2.77

389

1278

Other medical care

218

838

2.35

29.82

1.2

1.1

41.07

22.59

u/l

2.17

198

743

Other heart diseases

203

531

2.51

29.56

1.2

1.1

36.53

15.36

u/l

2.34

187

485

Diseases of arteries, arterioles and capillaries (FINNGEN)

127

275

3.22

29.35

1.2

1.1

57.09

15.20

u/l

2.97

118

251

Abnormalities of breathing

368

1089

1.97

29.27

1.1

23.10

22.28

u/l

0.11

327

994

Other and unspecified iron deficiency

171

666

2.58

29.21

1.1

39.32

23.12

u/l

1.10

155

594

Disorders of choroid and retina

362

1334

1.94

28.71

1.2

1.1

32.45

24.04

u/l

1.29

324

1196

Type 2 diabetes

417

1305

1.87

28.69

1.1

30.43

20.09

u/l

2.41

376

1182

Complications of procedures, not elsewhere classified

350

1501

1.94

28.65

1.1

25.81

23.18

u/l

0.37

322

1341

Other heart diseases, wide

379

1208

1.92

28.60

1.2

1.1

33.66

19.50

u/l

2.66

342

1104

Erysipelas

238

952

2.22

28.45

1.1

33.72

19.95

u/l

2.33

217

841

Other noninfective gastroenteritis and colitis

128

440

2.93

27.83

1.2

1.1

19.91

27.38

u/l

0.60

122

391

Bleeding

359

1336

1.92

27.75

1.2

1.1

31.99

23.74

u/l

1.15

323

1201

Endocrine, nutritional and metabolic diseases

286

675

2.15

27.68

1.2

1.1

21.39

17.64

u/l

0.59

259

616

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

257

3.58

27.44

1.1

49.23

28.02

u/l

1.41

236

Peripheral artery operations in Hilmo

204

3.91

27.08

1.2

1.1

67.95

26.50

u/l

1.82

181

Diabetic retinopathy, excluding more controls

151

297

2.87

27.06

1.2

1.1

42.10

25.66

u/l

1.38

136

264

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

278

1356

2.03

26.97

1.1

32.40

23.45

u/l

1.22

263

1206

Other soft tissue disorders, not elsewhere classified

378

1174

1.89

26.94

1.2

1.1

24.55

23.80

u/l

0.09

350

1053

Tramadol

328

1022

1.98

26.85

1.1

31.74

19.61

u/l

2.65

294

926

Diabetes medication

429

1408

1.81

26.77

1.1

33.04

20.02

u/l

3.05

386

1274

Pain in limb

335

1159

1.94

26.47

1.2

1.1

22.44

24.00

u/l

0.20

307

1038

Disorders of lens

304

954

2.00

25.65

1.2

1.1

32.73

22.72

u/l

1.23

277

860

Dermatitis

274

1368

2.00

25.65

1.2

1.1

26.74

24.67

u/l

0.20

250

1224

Diseases of the digestive system

208

938

2.22

25.37

1.2

1.1

38.05

24.37

u/l

1.14

186

833

Cirrhosis of liver, NAS

5.70

25.27

1.1

51.34

20.29

u/l

3.24

Gout, unspecified

105

345

3.07

24.84

1.1

43.25

30.61

u/l

0.58

304

Sleep apnoea

397

1432

1.80

24.79

1.1

21.00

26.02

u/l

1.15

353

1295

Other and unspecified dermatitis

233

1116

2.10

24.73

1.2

1.1

22.87

24.09

u/l

0.15

219

1002

Gout, strict definition

300

3.23

24.72

1.1

40.02

30.03

u/l

0.51

266

Constipation

379

1455

1.81

24.37

1.1

23.22

24.70

u/l

0.16

331

1317

Sleep apnoea, including avohilmo

410

1442

1.77

23.82

1.1

20.54

25.86

u/l

1.31

369

1303

Gout, idiopatic and unspecified

122

447

2.75

23.70

1.1

42.41

29.02

u/l

0.75

108

395

Disorders of the thyroid gland

381

1386

1.79

23.64

1.1

25.76

23.69

u/l

0.20

343

1259

Benzodiazepine use

408

1608

1.75

23.58

1.1

22.07

24.54

u/l

0.30

369

1451

Other and unspecified disorders of skin and subcutaneous tissue

5.13

23.56

1.2

1.1

26.07

22.66

u/l

0.23

Other diseases of intestines

410

1321

1.77

23.55

1.1

28.93

23.21

u/l

0.80

373

1196

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

115

404

2.83

23.55

1.1

54.56

24.83

u/l

1.78

105

351

Chronic pancreatitis

180

3.87

23.40

1.1

37.70

28.13

u/l

0.41

165

Diarrhoea and gastroenteritis of presumed infectious origin

288

1359

1.91

23.31

1.2

1.1

29.45

21.93

u/l

1.34

261

1221

Malaise and fatigue

212

796

2.15

23.13

1.1

31.63

22.09

u/l

1.61

192

718

Opioids

374

1069

1.82

23.12

1.2

1.1

27.60

19.09

u/l

1.95

341

969

Cardiovascular diseases (excluding rheumatic etc)

226

603

2.16

23.05

1.2

1.1

20.66

14.46

u/l

1.86

214

554

Systemic connective tissue disorders

169

739

2.30

22.58

1.1

29.65

23.04

u/l

0.71

159

657

Gastrointestinal diseases

199

435

2.30

22.51

1.1

17.81

17.58

u/l

0.03

185

389

Dyspnoea

370

1550

1.77

22.46

1.1

28.06

23.67

u/l

0.76

335

1401

Diabetic retinopathy

179

481

2.34

22.24

1.2

1.1

37.43

31.54

u/l

0.40

163

431

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

257

1327

1.94

22.09

1.1

31.89

24.07

u/l

0.92

242

1185

Hypothyroidism, other/unspecified

359

1327

1.78

21.94

1.2

1.1

25.24

23.73

u/l

0.13

319

1207

Medical observation and evaluation for suspected diseases and conditions

248

622

2.04

21.33

1.2

1.1

28.96

22.43

u/l

0.73

224

550

Neoplasms

248

647

2.04

21.32

1.1

24.40

18.75

u/l

0.84

233

571

Hypo-osmolality and hyponatraemia

316

2.98

21.21

1.2

1.1

34.41

26.14

u/l

0.51

283

Vitreous haemorrhage

175

3.76

21.13

1.3

1.1

37.13

29.54

u/l

0.36

159

Postmenopausal osteoporosis with pathological fracture

112

4.54

20.81

1.2

1.1

43.35

24.41

u/l

0.53

Diseases of peritoneum

182

3.67

20.73

1.2

1.1

20.90

25.30

u/l

0.46

166

Other diseases of biliary tract

133

4.18

20.73

1.3

1.1

29.87

27.37

u/l

0.16

121

Vocal cord dysfunction

160

3.72

20.67

1.1

31.53

16.98

u/l

0.35

147

Codeine

347

1059

1.78

20.39

1.1

22.11

19.19

u/l

0.50

315

959

Intestinal infectious diseases

368

1632

1.71

20.24

1.1

31.60

22.19

u/l

1.82

336

1471

Infections of the skin and subcutaneous tissue

232

1183

1.95

20.20

1.2

1.1

32.76

23.45

u/l

0.89

214

1071

Symptoms and signs involving the digestive system and abdomen

376

1082

1.74

20.10

1.1

27.47

23.41

u/l

0.56

339

976

Other diseases of pleura

196

835

2.07

19.67

1.1

37.79

26.27

u/l

1.62

174

729

Cerebrovascular diseases (FINNGEN)

135

391

2.45

19.43

1.1

44.86

15.82

u/l

2.05

120

358

Obesity due to excess calories

198

980

2.03

19.38

1.1

21.59

24.59

u/l

0.37

181

892

Parasetamol

255

664

1.95

19.32

1.2

28.50

20.43

u/l

1.24

232

607

COPD/asthma related infections

399

1184

1.69

19.13

1.2

1.1

24.79

22.62

u/l

0.37

365

1068

COPD/asthma/ILD related infections

399

1184

1.69

19.13

1.2

1.1

24.79

22.62

u/l

0.37

365

1068

Hypothyreosis and Thyroxine purchase for inclusion criteria

365

1409

1.70

19.09

1.1

25.05

23.66

u/l

0.12

324

1281

Abnormal findings on diagnostic imaging of lung

205

989

1.99

19.01

1.2

1.1

32.51

24.82

u/l

1.07

193

871

Sulfasalazine

127

530

2.41

18.96

1.1

20.42

23.34

u/l

0.26

116

472

Intestinal infectious diseases

443

1558

1.63

18.95

1.1

28.72

22.61

u/l

1.15

402

1404

Exposure to unspecified factor

382

1657

1.66

18.61

1.1

31.19

22.40

u/l

1.56

329

1514

Other cataract

191

706

2.06

18.41

1.2

1.1

37.26

24.00

u/l

1.43

174

629

Spondyloarthritis

255

3.04

18.08

1.1

26.53

29.29

u/l

0.14

231

Seropositive rheumatoid arthritis

116

475

2.45

17.93

1.1

24.26

24.18

u/l

0.01

106

424

Heart failure and coronary heart disease

186

641

2.06

17.88

1.2

1.1

44.82

25.28

u/l

2.31

168

555

Other disorders of urethra and urinary system

296

1215

1.76

17.86

1.2

1.1

22.86

24.41

u/l

0.21

263

1111

Other diseases of pancreas

123

4.03

17.62

1.1

55.51

27.07

u/l

0.98

112

Complications of internal orthopaedic prosthetic devices, implants and grafts

111

452

2.47

17.55

1.2

1.1

30.90

28.07

u/l

0.17

106

389

Cardiac arrhythmias

221

744

1.94

17.49

1.2

1.1

27.36

15.39

u/l

2.18

196

674

Other and unspecified polyneuropathies, also in other diseases

349

2.68

17.39

1.2

1.1

47.37

27.71

u/l

0.95

313

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

117

225

2.61

17.37

1.1

1.2

24.20

14.16

u/l

1.84

108

206

Antihypertensive medication - note that there are other indications

188

486

2.05

16.71

1.2

1.1

19.51

18.40

u/l

0.15

178

437

Rheumatoid arthritis

147

615

2.15

16.59

1.1

23.35

25.60

u/l

0.32

133

550

Other diseases of the digestive system

137

628

2.19

16.49

1.2

1.1

39.79

28.29

u/l

0.60

123

555

Cellulitis

388

2.54

16.46

1.2

1.1

37.36

24.28

u/l

0.85

349

Sleep disorders (combined)

422

1391

1.60

16.44

1.1

21.54

25.18

u/l

0.73

382

1254

Abdominal and pelvic pain

358

1082

1.67

16.35

1.1

22.90

23.41

u/l

0.05

318

976

Certain infectious and parasitic diseases

267

739

1.81

16.34

1.2

1.1

26.19

22.26

u/l

0.45

248

664

Other nutritional deficiencies

259

1390

1.76

16.30

1.1

21.77

24.08

u/l

0.34

238

1258

Other functional intestinal disorders

191

918

1.94

16.29

1.1

25.62

24.85

u/l

0.04

171

825

Other special examinations and investigations of persons without complaint or reported diagnosis

232

622

1.89

16.24

1.1

27.90

22.43

u/l

0.53

208

550

Heart failure and bmi 25plus

154

487

2.15

16.22

1.1

39.48

21.35

u/l

2.08

140

434

Chronic apical periodontitis

418

1506

1.58

16.10

1.2

1.1

22.85

24.26

u/l

0.21

375

1367

Diseases of the ear and mastoid process

427

1354

1.59

16.09

1.1

25.70

22.86

u/l

0.48

397

1217

Hyperlipidaemia, other/unspecified

158

709

2.06

15.99

1.2

1.1

30.47

21.72

u/l

0.93

140

625

Senile cataract

253

863

1.80

15.91

1.2

1.1

30.31

23.31

u/l

0.65

231

772

Hypothyroidism, strict autoimmune, 3 medication purchases required

326

1325

1.67

15.90

1.2

1.1

24.83

23.73

u/l

0.12

286

1202

Atrial fibrillation and flutter

131

375

2.27

15.73

1.1

37.68

15.87

u/l

2.52

117

343

Symptoms and signs involving the circulatory and respiratory systems

358

1091

1.65

15.70

1.1

22.20

22.25

u/l

0.01

325

996

All influenza

103

427

2.42

15.69

1.2

1.1

27.75

26.13

u/l

0.11

380

Hard cardiovascular diseases

331

1191

1.66

15.59

1.1

34.47

20.50

u/l

2.26

301

1079

Pain in throat and chest

303

1073

1.70

15.57

1.1

24.44

22.51

u/l

0.22

274

979

Cholecystectomy

288

1475

1.69

15.47

1.1

20.72

26.15

u/l

1.17

261

1323

Fall on same level

417

1451

1.57

15.45

1.2

1.1

27.33

22.03

u/l

0.83

365

1327

Valvular heart disease excluding rheumatic fever

184

683

1.95

15.33

1.1

39.18

20.82

u/l

1.79

168

611

Follow-up examination after treatment for conditions other than malignant neoplasms

169

554

2.02

15.32

1.2

1.1

17.04

22.22

u/l

1.35

156

487

Depression medications

123

3.11

15.27

1.1

1.2

17.99

9.97

u/l

1.58

113

Disorders of lipoprotein metabolism and other lipidaemias

310

1148

1.68

15.25

1.2

1.1

30.55

21.73

u/l

1.69

276

1034

Symptoms and signs involving the urinary system

296

1347

1.68

15.22

1.1

32.28

23.48

u/l

1.28

265

1215

Percutaneous Coronary Intervention

318

1174

1.66

15.20

1.1

35.44

21.95

u/l

1.89

292

1055

Non-rheumatic valve diseases

183

680

1.95

15.18

1.1

38.79

20.85

u/l

1.71

167

610

Peripheral artery disease

183

757

1.93

15.09

1.2

1.1

46.45

25.24

u/l

2.11

167

657

Diseases of arteries, arterioles and capillaries

257

1097

1.74

14.85

1.2

1.1

45.28

22.10

u/l

2.84

240

969

Exclusions for E4_PCOS_BROAD

280

2.73

14.77

1.1

39.75

26.31

u/l

0.39

258

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

163

509

2.03

14.69

1.2

1.1

23.38

15.65

u/l

1.84

155

468

Other bacterial intestinal infections

305

2.64

14.57

1.1

36.75

25.96

u/l

0.68

271

Emergency coronary revascularization (for ACS)

337

1267

1.62

14.53

1.1

35.64

23.02

u/l

1.81

307

1136

Obesity and other hyperalimentation

243

1359

1.73

14.47

1.1

21.51

24.14

u/l

0.38

223

1231

Ischemic heart diseases

326

1205

1.63

14.30

1.1

33.13

21.80

u/l

1.72

299

1085

Diarrhoea and gastroenteritis of presumed infectious origin

372

1565

1.57

14.30

1.2

1.1

25.77

22.48

u/l

0.55

337

1409

Coronary revascularization (ANGIO or CABG)

314

1174

1.64

14.27

1.1

35.49

21.95

u/l

1.87

288

1055

Other systemic involvement of connective tissue (FG)

108

472

2.27

14.18

1.1

32.99

22.75

u/l

0.74

419

Obesity

241

1356

1.72

14.13

1.1

21.52

24.11

u/l

0.38

222

1228

Fitting and adjustment of other devices

144

642

2.03

14.09

1.1

27.29

24.72

u/l

0.17

134

558

Polyneuropathies and other disorders of the peripheral nervous system

412

2.37

14.08

1.2

1.1

46.20

26.37

u/l

1.02

370

GI-bleeding

130

623

2.09

14.04

1.2

1.1

41.43

28.25

u/l

0.67

116

553

Mycoses

115

526

2.20

14.01

1.1

34.07

26.88

u/l

0.51

103

471

Continuous positive airway pressure

238

2.70

14.00

1.1

1.2

17.87

16.99

u/l

0.11

212

Pain in joint

213

750

1.82

13.95

1.2

1.1

17.14

25.45

u/l

2.33

194

682

Syncope and collapse

163

722

1.94

13.84

1.1

30.29

21.70

u/l

0.85

147

645

Major coronary heart disease event

329

1238

1.61

13.74

1.1

35.45

22.14

u/l

1.95

302

1109

Fracture of femur

117

490

2.17

13.67

1.1

40.45

27.84

u/l

0.71

435

Gastroduodenal ulcer

107

479

2.24

13.64

1.1

40.59

30.64

u/l

0.65

421

Dipeptidyl peptidase 4 (DPP-4) inhibitors

225

1034

1.75

13.58

1.1

32.68

24.17

u/l

0.99

200

927

Non-ischemic cardiomyopathy

133

517

2.08

13.55

1.1

33.33

22.58

u/l

1.59

115

452

Other arthritis (FG)

122

581

2.11

13.43

1.1

33.60

23.18

u/l

0.55

115

523

Coagulation defects, purpura and other haemorrhagic conditions

354

2.44

13.40

1.2

1.1

31.06

27.44

u/l

0.16

321

Abnormal findings on diagnostic imaging of other body structures

250

2.74

13.35

1.1

35.99

23.80

u/l

0.54

221

Cutaneous abscess, furuncle and carbuncle

103

460

2.25

13.32

1.2

1.1

28.71

22.58

u/l

0.35

418

Missing teeth due to accident, extraction or parodontitis

235

1305

1.70

13.25

1.1

24.88

25.74

u/l

0.07

206

1169

Corns and callosities

3.98

13.16

1.4

1.1

44.68

22.22

u/l

0.62

Cholecystitis

224

2.83

13.16

1.1

42.19

29.14

u/l

0.65

202

Injuries to the hip and thigh

185

922

1.82

13.15

1.2

1.1

35.54

25.96

u/l

0.80

160

820

Intracranial trauma

201

787

1.80

13.11

1.1

25.56

20.90

u/l

0.45

170

715

Psoriasis

120

574

2.10

13.08

1.1

24.99

24.77

u/l

0.01

109

518

Presence of cardiac and vascular implants and grafts

157

603

1.94

13.06

1.2

1.1

36.51

28.41

u/l

0.71

142

525

Familial hypercholesterolemia, with ischemic heart disease

153

3.23

12.84

1.2

1.1

56.44

30.01

u/l

0.75

136

Symptoms and signs concerning food and fluid intake

148

3.26

12.79

1.0

1.1

17.16

23.58

u/l

0.69

136

AV-block

256

2.58

12.77

1.1

30.71

28.28

u/l

0.16

226

Atrial fibrillation and flutter with reimbursement

104

290

2.29

12.74

1.1

29.27

16.22

u/l

2.45

262

Hypertensive heart and/or renal disease

107

363

2.21

12.53

1.2

1.1

33.90

21.34

u/l

1.22

319

Bacterial intestinal infections, IBD co-morbidities

341

2.42

12.53

1.1

40.87

27.23

u/l

0.82

303

Asthma, unspecified (mode), excluding more controls

180

739

1.83

12.50

1.1

17.83

19.56

u/l

0.33

168

660

Gastric ulcer

324

2.45

12.44

1.1

44.60

30.57

u/l

0.78

282

420

1455

1.49

12.36

1.2

1.1

23.49

23.85

u/l

0.05

379

1311

Cough

159

810

1.86

12.25

1.1

20.22

25.13

u/l

0.56

144

733

Unspecified urinary incontinence

184

2.96

12.24

1.1

25.49

25.27

u/l

0.01

170

Gonarthrosis [arthrosis of knee](FG)

271

965

1.64

12.13

1.1

25.18

23.69

u/l

0.12

244

870

Other antidepressants

369

1238

1.53

12.11

1.1

22.06

25.92

u/l

0.77

335

1126

Pure hypercholesterolaemia

271

1091

1.62

12.09

1.1

34.98

21.76

u/l

1.94

243

980

Fracture of lumbar spine and pelvis

421

2.24

12.08

1.2

1.1

28.42

29.12

u/l

0.05

373

Papulosquamous disorders

157

850

1.85

12.02

1.1

23.56

25.84

u/l

0.15

144

763

Non-invasive ventilation

325

2.34

11.90

1.1

31.26

16.37

u/l

1.65

298

Nerve, nerve root and plexus disorders

385

1579

1.50

11.84

1.2

1.1

25.55

23.72

u/l

0.25

358

1418

Cardiovascular diseases

175

509

1.85

11.82

1.2

1.1

20.88

14.73

u/l

1.36

164

467

Other diseases of urinary system

363

1345

1.52

11.81

1.1

23.46

24.46

u/l

0.13

316

1230

Excluding asthma or asthma-COPD overlap

274

842

1.63

11.80

1.2

1.1

22.16

21.43

u/l

0.09

254

750

Diseases of the eye and adnexa

263

800

1.65

11.77

1.2

1.1

21.40

21.13

u/l

0.03

241

735

Viral infections characterized by skin and mucous membrane lesions

156

848

1.84

11.76

1.2

1.1

23.92

25.72

u/l

0.18

147

763

Atherosclerosis, excluding cerebral and coronary sclerosis

164

709

1.84

11.75

1.2

1.1

49.29

25.57

u/l

2.13

149

612

Codeine or tramadol medication

403

1486

1.49

11.74

1.1

22.30

24.34

u/l

0.33

358

1344

Other reaction to severe stress, and adjustment disorders

136

710

1.92

11.65

1.3

1.1

36.32

20.15

u/l

0.98

131

646

Rheumatoid arthritis, including avohilmo

157

859

1.83

11.64

1.1

25.40

24.66

u/l

0.09

143

772

Other pulmonary diagnosis

273

842

1.63

11.60

1.2

1.1

21.36

21.43

u/l

0.01

253

750

Other specified/unspecified arthritis

109

528

2.07

11.55

1.1

34.27

24.31

u/l

0.45

103

474

Sequelae of external causes of morbidity and mortality

106

510

2.09

11.45

1.2

1.1

32.89

26.90

u/l

0.42

100

449

Malignant neoplasm of prostate

246

2.29

11.43

1.2

1.1

18.44

29.29

u/l

1.52

215

Pain, not elsewhere classified

104

498

2.10

11.36

1.1

19.43

19.95

u/l

0.06

451

Sequelae with surgical and medical care as external cause

401

2.23

11.36

1.2

1.1

27.21

28.25

u/l

0.07

359

Episodal and paroxysmal disorders

379

1289

1.50

11.34

1.1

21.70

24.18

u/l

0.48

349

1159

Other specific joint derangements/joint disorders

242

953

1.64

11.33

1.2

1.1

20.24

22.53

u/l

0.36

222

864

Zoster [herpes zoster]

370

2.28

11.32

1.2

1.1

21.43

27.10

u/l

0.50

332

Candidiasis

115

573

2.02

11.30

1.2

1.1

28.74

23.57

u/l

0.39

100

515

STROKE

210

841

1.70

11.30

1.1

41.07

19.29

u/l

2.21

191

761

Viral infections characterized by skin and mucous membrane lesions

305

1701

1.54

11.26

1.2

1.1

20.84

24.43

u/l

0.85

282

1530

Acute pancreatitis

328

2.36

11.20

1.2

1.1

52.31

26.67

u/l

0.80

299

Other/unspecified seropositive rheumatoid arthritis

116

582

2.00

11.19

1.1

24.26

24.70

u/l

0.05

106

521

Type 2 diabetes, definitions combined, including avohilmo

333

1273

1.53

11.17

1.1

28.84

21.27

u/l

1.38

303

1152

Thyrotoxicosis with diffuse goitre

257

2.54

11.11

1.2

1.1

13.48

21.39

u/l

1.70

233

Recurrent or chronic depression

153

581

1.86

11.11

1.2

22.43

22.18

u/l

0.02

138

541

Disorders of vitreous body and globe

209

1208

1.67

11.04

1.2

1.1

25.52

26.34

u/l

0.07

194

1080

Other diseases of anus and rectum

120

611

1.97

11.03

1.1

21.62

26.44

u/l

0.66

549

Other symptoms and signs involving the digestive system and abdomen

306

2.40

11.02

1.2

1.1

27.11

22.45

u/l

0.29

277

Asthma, excluding more controls

243

771

1.65

10.95

1.1

19.64

19.04

u/l

0.09

228

691

Other bacterial intestinal infections

414

2.18

10.93

1.1

33.69

23.79

u/l

0.71

373

Thyrotoxicosis, other and/or unspecified

395

2.21

10.91

1.2

1.1

15.79

23.47

u/l

1.52

357

Fentanyl

164

2.94

10.82

1.0

1.1

59.87

32.03

u/l

1.20

146

Type 2 diabetes, definitions combined

329

1275

1.52

10.79

1.1

28.89

20.37

u/l

1.65

297

1152

Seropositive rheumatoid arthritis, wide

116

590

1.98

10.79

1.1

24.26

24.75

u/l

0.05

106

529

COPD differential diagnosis

269

844

1.60

10.72

1.1

22.26

21.72

u/l

0.07

249

751

ILD differential diagnosis

269

844

1.60

10.72

1.1

22.26

21.72

u/l

0.07

249

751

Disorders of vitreous body

204

1189

1.66

10.70

1.2

1.1

25.75

26.03

u/l

0.02

189

1061

Other systemic involvement of connective tissue

111

558

2.00

10.67

1.1

33.17

24.23

u/l

0.64

101

495

Intestinal stricture

125

655

1.92

10.65

1.2

1.1

38.60

26.58

u/l

0.81

118

579

Disorders of continuity of bone

150

3.02

10.63

1.2

1.1

32.91

19.71

u/l

0.41

137

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

113

573

1.98

10.61

1.1

24.49

24.70

u/l

0.02

103

513

Familial hypercholesterolemia

263

2.49

10.61

1.2

1.1

53.39

25.46

u/l

1.02

235

Smoking dependency

145

3.06

10.61

1.1

22.92

23.00

u/l

0.00

135

malignant neoplasm of male genital organs

264

2.20

10.58

1.2

1.1

18.21

28.44

u/l

1.51

233

Other diseases of the respiratory system

394

2.19

10.57

1.1

34.76

29.28

u/l

0.34

350

Other respiratory disorders and diseases

394

2.19

10.57

1.1

34.76

29.28

u/l

0.34

350

Primary_lymphoid and hematopoietic malignant neoplasms

480

2.07

10.52

1.1

38.50

28.32

u/l

0.84

426

Peripheral arterial reconstruction

295

2.39

10.46

1.2

1.1

56.01

28.43

u/l

1.33

260

Irritable bowel syndrome

108

542

2.00

10.44

1.1

17.35

22.85

u/l

0.94

493

Mental and behavioural disorders due to tobacco

148

3.00

10.25

1.1

22.92

22.73

u/l

0.01

137

Type 2 diabetes, strict (exclude DM1)

329

1290

1.50

10.25

1.1

28.89

21.31

u/l

1.36

297

1166

Other symptoms and signs involving the nervous and musculoskeletal systems

159

909

1.75

10.23

1.1

24.58

24.54

u/l

0.00

148

818

Asthma, unspecified (mode)

181

798

1.71

10.21

1.1

17.98

22.22

u/l

0.94

169

707

Anxiety disorders, excluding more controls

290

1235

1.53

10.13

1.2

1.1

27.70

21.71

u/l

0.57

271

1127

Falls/tendency to fall

372

1274

1.46

9.98

1.1

27.00

22.34

u/l

0.67

330

1173

Chronic laryngitis and laryngotracheitis

271

2.41

9.98

1.2

1.1

32.86

26.52

u/l

0.14

247

Viral pneumonia

189

2.71

9.96

1.2

1.1

36.00

27.05

u/l

0.34

174

Other (not insulin) diabetes medications

338

1358

1.48

9.88

1.1

28.29

20.68

u/l

1.42

304

1227

Paralytic ileus and intestinal obstruction

103

519

1.99

9.86

1.2

1.1

41.08

27.42

u/l

0.73

462

Thyrotoxicosis

107

547

1.96

9.85

1.1

16.37

24.47

u/l

1.82

492

Persons encountering health services for examination and investigation

207

622

1.67

9.85

1.1

26.89

22.43

u/l

0.50

192

550

Zoster [herpes zoster]

190

1135

1.65

9.82

1.2

1.1

19.89

25.04

u/l

1.07

174

1008

Leisure time condition

305

2.31

9.73

1.1

24.65

26.08

u/l

0.11

278

Other respiratory diseases principally affecting the interstitium

350

2.21

9.69

1.2

1.1

32.78

28.16

u/l

0.29

314

Diseases of external ear

125

677

1.85

9.67

1.1

26.46

24.41

u/l

0.13

118

604

Other disorders of ear

328

1458

1.48

9.67

1.1

24.83

24.91

u/l

0.01

299

1309

Concussion

164

779

1.72

9.61

1.1

23.47

20.95

u/l

0.21

140

707

Any mental disorder

388

1350

1.44

9.61

1.1

29.22

21.97

u/l

0.96

347

1226

Headache

205

1010

1.62

9.61

1.1

22.68

20.59

u/l

0.18

181

915

Diseases of the respiratory system

230

715

1.61

9.59

1.1

22.65

24.75

u/l

0.25

211

639

Candidiasis

246

2.45

9.57

1.2

1.1

31.78

23.30

u/l

0.42

223

Myocardial infarction

176

731

1.70

9.54

1.1

50.35

22.73

u/l

2.15

160

642

Asthma (mode)

248

844

1.58

9.51

1.1

19.76

21.72

u/l

0.31

232

751

Supplementary factors related to causes of morbidity and mortality classified elsewhere

115

610

1.89

9.50

1.2

1.1

32.25

23.16

u/l

0.61

102

551

Asthma

250

834

1.57

9.50

1.1

19.73

21.56

u/l

0.28

234

742

Genitourinary diseases

166

474

1.76

9.47

1.1

27.80

22.32

u/l

0.47

150

429

Alcoholic liver disease

156

2.84

9.36

1.0

1.1

48.61

33.51

u/l

0.37

143

Low back pain

265

1249

1.53

9.35

1.1

16.65

25.21

u/l

3.60

236

1125

Asthma (only as main-diagnosis), excluding more controls

217

771

1.61

9.28

1.1

19.72

19.04

u/l

0.08

202

691

Malignant neoplasm of breast, HER-negative

375

2.13

9.28

1.1

18.02

17.49

u/l

0.05

324

Mood disorders, excluding more controls

327

1332

1.47

9.25

1.1

22.63

21.99

u/l

0.06

291

1211

Functional dyspepsia

103

532

1.94

9.23

1.1

20.65

24.44

u/l

0.49

481

Any death

230

1053

1.57

9.15

1.2

1.1

64.37

18.65

u/l

6.49

212

936

Unspecified haematuria

149

714

1.73

9.02

1.1

27.34

25.99

u/l

0.11

133

637

Malignant neoplasm of prostate, including Hilmo

256

2.10

8.93

1.2

1.1

18.29

28.74

u/l

1.47

225

Arthropathies

289

976

1.50

8.89

1.2

1.1

22.70

22.35

u/l

0.04

271

884

Psoriasis vulgaris

345

2.15

8.79

1.2

1.1

24.28

26.62

u/l

0.12

314

Haemorrhage from respiratory passages

122

607

1.82

8.78

1.1

27.49

26.47

u/l

0.09

105

541

Interstitial lung disease

275

2.30

8.77

1.2

1.1

34.29

30.60

u/l

0.17

244

Interstitial lung disease endpoints

275

2.30

8.77

1.2

1.1

34.29

30.60

u/l

0.17

244

Other interstitial pulmonary diseases

276

2.30

8.70

1.2

1.1

34.29

30.68

u/l

0.17

245

Other joint disorders

278

976

1.50

8.69

1.1

17.50

22.35

u/l

1.39

250

884

Covid-19 confirmed case

133

760

1.76

8.66

1.2

1.1

32.53

25.42

u/l

0.74

125

673

Acquired absence of limb

11.97

8.65

1.1

1.2

48.27

40.60

u/l

0.12

Secondary uncertain malignant neoplasm

210

2.49

8.60

1.2

1.1

54.20

23.07

u/l

2.07

183

Neurotic, stress-related and somatoform disorders

301

1445

1.46

8.57

1.2

1.1

29.14

22.50

u/l

0.66

282

1310

Exposure to other specified factors

255

1568

1.50

8.55

1.2

1.1

25.29

22.99

u/l

0.23

223

1429

Neurological diseases

277

930

1.50

8.43

1.2

1.1

26.60

22.91

u/l

0.45

252

838

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

253

2.31

8.40

1.2

1.1

20.18

27.03

u/l

0.58

232

Statin medication

238

873

1.54

8.31

1.2

1.1

22.55

23.15

u/l

0.06

218

802

Myocardial infarction, strict

162

694

1.67

8.29

1.1

49.71

23.44

u/l

1.97

146

609

Benign neoplasm of colon, rectum, anus and anal canal

229

1310

1.52

8.27

1.1

28.60

25.78

u/l

0.31

207

1170

Depression

322

1526

1.43

8.26

1.1

22.67

24.13

u/l

0.13

286

1388

ILD, hospital admissions

270

2.27

8.25

1.2

1.1

34.61

30.79

u/l

0.17

239

Congenital malformations, deformations and chromosomal abnormalities

190

1149

1.58

8.20

1.2

1.1

24.71

23.64

u/l

0.09

175

1051

Other CVD

375

2.06

8.19

1.1

34.05

28.72

u/l

0.19

336

Coronary atherosclerosis

230

952

1.53

8.14

1.1

38.81

22.47

u/l

2.09

212

849

Anxiety disorders

302

1461

1.44

8.11

1.2

1.1

29.06

22.48

u/l

0.65

283

1324

Acute pancreatitis (for exclusion)

377

2.05

8.08

1.2

1.1

52.31

28.73

u/l

0.71

340

Acute upper respiratory infections

360

1584

1.40

8.08

1.2

1.1

22.07

24.57

u/l

0.49

329

1425

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

318

2.15

8.05

1.2

1.1

62.10

26.13

u/l

1.62

274

Injuries to the abdomen, lower back, lumbar spine and pelvis

136

792

1.70

7.99

1.2

1.1

27.07

25.97

u/l

0.10

122

705

Malignant neoplasm of breast, ER-negative, including Hilmo

413

1.97

7.91

1.1

17.52

18.34

u/l

0.09

357

Pleural effusion

282

2.21

7.88

1.1

50.04

30.52

u/l

1.10

250

Soft tissue disorders

328

1185

1.43

7.87

1.2

1.1

25.91

23.68

u/l

0.26

301

1063

Type of accident

103

563

1.84

7.84

1.2

1.1

33.50

23.00

u/l

0.64

509

Myocardial infarction, without ST-elevation

142

774

1.68

7.78

1.2

1.1

52.90

26.83

u/l

1.79

128

678

Mood disorders

346

1602

1.40

7.78

1.2

1.1

22.90

24.17

u/l

0.12

309

1455

Mood [affective] disorders

345

1600

1.40

7.76

1.2

1.1

22.93

24.16

u/l

0.12

308

1455

Conduction disorders

103

453

1.85

7.75

1.1

28.67

24.40

u/l

0.46

400

Weight loss

173

2.56

7.74

1.0

1.1

17.26

27.32

u/l

1.16

154

Conductive and sensorineural hearing loss

279

1299

1.45

7.73

1.1

24.99

25.30

u/l

0.03

247

1166

Coxarthrosis [arthrosis of hip](FG)

183

814

1.59

7.71

1.1

23.15

23.16

u/l

0.00

161

729

Depression or dysthymia

234

854

1.51

7.70

1.2

1.1

23.67

23.91

u/l

0.02

210

783

Chronic gastritis

538

1.85

7.68

1.1

20.38

28.31

u/l

1.43

475

Diseases of pulp and periapical tissues, including avohilmo

348

1285

1.40

7.67

1.2

1.1

23.78

25.27

u/l

0.18

316

1164

Periodontitis

334

1600

1.40

7.53

1.2

1.1

18.86

25.52

u/l

2.60

298

1447

Chronic periodontitis, including avohilmo

333

1599

1.40

7.50

1.2

1.1

18.90

25.53

u/l

2.57

297

1446

Asthma (only as main-diagnosis)

219

834

1.52

7.46

1.1

19.69

21.56

u/l

0.24

204

742

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

242

2.25

7.43

1.2

1.1

20.94

26.57

u/l

0.42

222

Chronic lower respiratory diseases

402

1574

1.36

7.42

1.1

21.08

24.81

u/l

0.81

371

1421

Other arrhythmias

213

1064

1.51

7.41

1.1

21.44

19.73

u/l

0.33

190

969

Bronchitis

358

1636

1.38

7.40

1.2

1.1

25.72

23.52

u/l

0.35

325

1477

Ischaemic heart disease, wide definition

277

1190

1.44

7.39

1.2

1.1

38.38

21.96

u/l

2.13

253

1068

Acute bronchitis

139

825

1.66

7.38

1.2

1.1

29.39

24.41

u/l

0.61

125

735

Major coronary heart disease event excluding revascularizations

206

900

1.53

7.34

1.1

45.16

22.20

u/l

2.13

189

796

Gonarthrosis

223

842

1.51

7.33

1.1

26.35

24.73

u/l

0.10

201

760

Sensorineural hearing loss

263

1233

1.45

7.30

1.1

25.88

25.97

u/l

0.01

233

1101

Disorders of synovium and tendon

182

1030

1.55

7.26

1.1

32.79

24.13

u/l

0.70

165

924

Retention of urine

113

530

1.75

7.22

1.1

39.71

26.70

u/l

0.79

478

Other CVD (FINNGEN)

140

2.50

7.19

1.2

1.1

39.57

17.70

u/l

0.62

125

Other gastritis (incl. Duodenitis)

415

1.93

7.19

1.1

36.16

28.53

u/l

0.36

368

Diseases of the musculoskeletal system and connective tissue

155

472

1.65

7.17

1.1

19.05

21.60

u/l

0.34

143

423

Alcohol use disorder, Swedish definition

175

1033

1.56

7.15

1.1

42.99

22.71

u/l

1.35

151

939

Use of hypnotics and sedatives

360

1507

1.37

7.13

1.1

27.07

23.72

u/l

0.47

321

1367

Internal derangement of knee

128

764

1.67

7.08

1.2

1.1

18.11

24.47

u/l

1.44

123

689

Faecal incontinence

163

2.53

7.08

1.1

12.16

22.76

u/l

2.52

147

Lower back pain or/and sciatica

350

1671

1.37

6.99

1.1

17.69

25.47

u/l

3.03

315

1511

Other skin changes

371

1.98

6.98

1.2

1.1

45.71

27.45

u/l

0.87

329

Carbimazole or st.post thyroidectomy, condition for graves disease

434

1.90

6.96

1.1

12.96

21.98

u/l

3.17

395

Benign neoplasm: Colon

192

1214

1.51

6.95

1.2

1.1

30.25

24.97

u/l

0.59

177

1076

Idiopathic gout

147

2.60

6.94

1.0

1.1

33.13

37.09

u/l

0.18

135

Gout due to impairment of renal function

8.50

6.88

1.2

19.93

41.82

u/l

0.88

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

462

1.86

6.87

1.2

1.1

16.57

21.75

u/l

1.03

424

Seronegative rheumatoid arthritis

202

2.34

6.87

1.1

21.00

25.05

u/l

0.37

177

Benign neoplasm of other and ill-defined parts of digestive system

367

1.97

6.84

1.1

22.71

28.68

u/l

0.73

328

Pain (limb, back, neck, head abdominally)

228

771

1.48

6.73

1.1

27.73

25.59

u/l

0.16

207

699

Benign neoplasms

305

1205

1.40

6.67

1.2

1.1

30.44

22.38

u/l

0.91

278

1091

Other or unspecified ileus, impaction or obstruction

329

2.01

6.67

1.3

1.1

28.73

27.87

u/l

0.03

291

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

263

2.14

6.63

1.2

1.1

17.71

20.70

u/l

0.32

248

Other acute lower respiratory infections

169

1049

1.54

6.63

1.1

31.28

25.58

u/l

0.70

152

941

Polycystic ovarian syndrome, consortium definition

247

1014

1.45

6.62

1.2

1.1

17.66

21.05

u/l

0.75

221

926

Substance abuse, excluding more controls

176

983

1.53

6.62

1.1

40.56

21.60

u/l

1.33

150

897

Gingivitis and periodontal diseases

345

1302

1.37

6.61

1.1

19.68

26.60

u/l

2.04

309

1180

Chronic myeloproliferative disease

8.87

6.59

1.2

1.1

60.17

44.87

u/l

0.36

Mycoses

278

1734

1.40

6.55

1.1

26.20

23.48

u/l

0.32

245

1573

Substance use, excluding alcohol

325

2.01

6.53

1.2

1.1

22.21

24.26

u/l

0.14

300

Other diseases of oesophagus

140

2.58

6.52

1.1

1.2

52.79

40.41

u/l

0.13

130

Acute upper respiratory infections of multiple and unspecified sites

245

1270

1.43

6.51

1.2

1.1

23.31

23.96

u/l

0.08

227

1143

L01XE Protein kinase inhibitors

3.09

6.47

1.2

1.1

73.12

27.23

u/l

1.70

Respiratory insufficiency

123

2.69

6.46

1.1

23.63

24.94

u/l

0.07

110

Infection of intervertebral disc (pyogenic)

7.55

6.45

1.1

55.00

38.26

u/l

0.27

190

1122

1.49

6.44

1.1

42.46

22.37

u/l

1.52

165

1020

Injuries to the elbow and forearm

237

1460

1.43

6.40

1.2

1.1

22.42

24.50

u/l

0.32

206

1324

Examination and observation for other reasons

167

621

1.56

6.39

1.2

1.1

31.38

22.47

u/l

0.75

156

549

COPD (mode)

101

455

1.75

6.38

1.2

1.1

20.31

24.52

u/l

0.53

392

Failure and rejection of transplanted organs and tissues

6.69

6.38

1.2

1.1

70.67

24.21

u/l

0.86

Congenital malformations, deformations and chromosomal abnormalities

202

1270

1.47

6.33

1.2

1.1

24.07

23.03

u/l

0.09

186

1155

Abnormal spermatozoa

185

2.34

6.30

1.2

1.1

21.22

42.08

u/l

1.98

167

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

120

732

1.64

6.29

1.2

1.1

26.94

23.20

u/l

0.15

108

663

Disorders of sclera, cornea, iris and ciliary body

182

1222

1.49

6.27

1.1

20.88

25.55

u/l

0.70

168

1100

Diverticular disease of intestine

242

1082

1.43

6.25

1.2

1.1

20.99

24.91

u/l

0.64

214

972

Early onset COPD, excluding more controls

351

1.94

6.24

1.1

21.17

25.01

u/l

0.35

309

Other disorders of lacrimal gland

130

812

1.61

6.21

1.1

20.17

24.66

u/l

0.65

117

737

Adalimumab

144

2.51

6.18

1.1

22.24

21.37

u/l

0.02

135

Immunodeficiencies

3.14

6.17

1.3

1.1

53.08

26.35

u/l

0.72

Pulmonary heart disease, diseases of pulmonary circulation

112

675

1.66

6.16

1.1

40.59

26.18

u/l

1.37

105

592

Disorders of myoneural junction and muscle in diseases classified elsewhere

10.34

6.08

1.0

1.2

46.55

17.61

u/l

0.97

Disorders of eyelid, lacrimal system and orbit

290

1607

1.37

6.08

1.1

21.69

24.72

u/l

0.48

260

1450

Dental operations

198

683

1.49

6.08

1.1

26.90

26.88

u/l

0.00

185

621

Diseases of oral cavity, salivary glands and jaws

195

672

1.49

6.06

1.1

21.43

28.60

u/l

1.34

181

608

Caries of dentine, including avohilmo

257

928

1.42

6.05

1.1

25.78

24.61

u/l

0.10

237

843

Infective dermatitis

178

2.31

5.91

1.1

54.97

28.10

u/l

0.56

163

Hypertensive Heart Disease

338

1.84

5.89

1.2

1.1

33.38

21.89

u/l

0.92

296

Psychiatric diseases

326

1210

1.35

5.78

1.2

1.1

30.07

21.90

u/l

0.92

295

1099

Cystitis

285

1237

1.37

5.75

1.1

19.71

24.13

u/l

1.12

248

1132

Mental and behavioural disorders due to psychoactive substance use

185

1174

1.46

5.74

1.1

40.12

22.71

u/l

1.26

158

1070

Degeneration of macula and posterior pole

161

850

1.51

5.72

1.2

1.1

26.28

24.82

u/l

0.17

144

747

Symptoms and signs involving the skin and subcutaneous tissue

234

1644

1.39

5.65

1.2

1.1

28.09

23.60

u/l

0.54

220

1469

Symptoms and signs involving the nervous and musculoskeletal systems

192

1334

1.44

5.59

1.1

24.37

23.95

u/l

0.02

175

1195

Polyarthrosis

405

1.79

5.58

1.2

1.1

25.20

23.40

u/l

0.14

360

Poisoning by medicine

366

1.86

5.57

1.2

1.1

18.25

19.81

u/l

0.15

340

Benign neoplasm: Liver/bile ducts

3.86

5.55

1.1

31.51

28.98

u/l

0.09

Aortic valve malfunction, age under 60 years

152

2.38

5.54

1.2

1.1

55.36

26.73

u/l

0.47

144

Cerebrovascular diseases

246

1247

1.39

5.52

1.1

40.80

23.76

u/l

1.75

215

1119

Any operation in hilmo

8.34

5.49

1.1

1.0

22.75

5.38

u/l

—

Injuries to the head

355

1661

1.31

5.49

1.1

30.41

22.31

u/l

0.94

296

1525

Open wound of head

169

1108

1.47

5.48

1.1

27.55

23.56

u/l

0.55

143

1006

Other diseases of hard tissues of teeth

189

666

1.47

5.47

1.1

25.95

28.63

u/l

0.23

177

603

Intracranial injury

186

1219

1.45

5.47

1.1

26.29

23.00

u/l

0.27

156

1107

Stroke, excluding SAH

198

1007

1.44

5.45

1.1

45.24

23.37

u/l

1.83

168

899

Presence of other devices

432

1.78

5.45

1.1

17.30

28.37

u/l

2.22

381

Dental caries, including avohilmo

239

871

1.41

5.44

1.1

26.52

24.97

u/l

0.13

223

792

Pacemaker

111

662

1.61

5.40

1.1

33.79

29.59

u/l

0.34

574

Coxarthrosis

167

742

1.49

5.40

1.1

23.99

23.85

u/l

0.01

147

666

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

317

1526

1.33

5.39

1.1

23.68

24.35

u/l

0.09

285

1384

Abnormalities of heart beat

114

701

1.60

5.39

1.1

22.48

24.96

u/l

0.24

103

634

Non-selective monoamine reuptake inhibitors

134

841

1.54

5.38

1.1

19.92

28.45

u/l

1.24

123

759

175

1086

1.46

5.37

1.1

41.12

23.15

u/l

1.25

151

988

Hypotension

300

1.94

5.37

1.2

1.1

38.87

30.24

u/l

0.23

270

Infections with a predominantly sexual mode of transmission

532

1.69

5.35

1.2

1.1

36.95

18.02

u/l

1.18

496

Viral and other specified intestinal infections

385

1.81

5.35

1.2

1.1

27.64

17.00

u/l

0.48

349

Other abnormal uterine and vaginal bleeding

377

1.71

5.30

1.2

1.1

21.37

24.05

u/l

0.24

341

Disorders of lacrimal system

151

1011

1.49

5.29

1.1

20.10

24.48

u/l

0.74

137

913

Contact with and exposure to communicable diseases

488

1.72

5.27

1.2

1.1

23.68

17.73

u/l

0.39

455

Fracture of rib(s), sternum and thoracic spine

582

1.65

5.24

1.1

29.66

29.00

u/l

0.02

521

Gonarthrosis, primary, with knee surgery

204

1150

1.41

5.23

1.1

25.28

25.23

u/l

0.01

181

1026

Stroke, including SAH

209

1076

1.41

5.21

1.1

43.81

23.63

u/l

1.78

180

967

Selective serotonin reuptake inhibitors

316

1240

1.33

5.20

1.1

20.37

25.94

u/l

1.19

280

1127

Dysphagia

448

1.75

5.19

1.1

23.41

26.21

u/l

0.18

399

Isolated proteinuria with specified morphological lesion

7.50

5.17

1.2

1.1

27.00

25.58

u/l

0.03

Dorsalgia

314

1266

1.33

5.15

1.1

19.25

25.00

u/l

1.47

284

1141

severe traumatic brain injury, does not include concussion

405

1.78

5.15

1.1

31.54

30.38

u/l

0.05

363

Biguanides

314

1446

1.32

5.14

1.1

26.64

23.50

u/l

0.40

281

1309

Substance abuse

176

1149

1.44

5.13

1.1

40.56

23.09

u/l

1.18

150

1048

Traumatic subdural haemorrhage

207

2.09

5.11

1.1

37.24

23.72

u/l

0.51

181

Primary gonarthrosis, bilateral

183

1096

1.43

5.10

1.1

26.11

25.77

u/l

0.03

161

982

Exclusions for E4_PCOS_CONSORTIUM

236

1071

1.38

5.10

1.2

1.1

25.90

21.38

u/l

0.37

218

972

Suicide or other Intentional self-harm

451

1.73

5.08

1.2

17.23

22.31

u/l

0.89

413

Other diseases of intestine

251

2.00

5.06

1.1

23.34

29.60

u/l

0.49

225

Acute sinusitis

159

1006

1.47

5.05

1.1

19.13

24.73

u/l

1.08

145

911

Disorders of conjunctiva

263

1569

1.35

5.04

1.2

1.1

20.89

24.72

u/l

0.60

245

1414

Psoriasis (vulgaris), strict definition

3.43

5.03

1.1

10.04

26.24

u/l

1.85

Malignant neoplasm of skin

149

684

1.50

5.00

1.2

1.1

26.09

23.18

u/l

0.29

135

594

Myalgia

446

1.73

4.99

1.1

27.02

22.28

u/l

0.28

398

Malignant melanoma, including Hilmo

294

1.91

4.99

1.2

1.1

24.55

24.37

u/l

0.01

256

Injuries to the thorax

142

954

1.49

4.97

1.2

1.1

26.94

26.15

u/l

0.04

128

848

Benign neoplasm: Liver

3.70

4.94

1.1

30.01

29.54

u/l

0.01

Arthrosis

224

885

1.39

4.92

1.1

26.77

24.03

u/l

0.19

204

800

Pulmonary embolism

616

1.61

4.90

1.2

1.1

41.64

26.76

u/l

1.23

544

In situ neoplasms

129

855

1.51

4.85

1.1

22.60

24.14

u/l

0.20

120

758

Fibrosis of liver

9.28

4.82

1.3

1.2

52.67

25.57

u/l

—

Pulmonary heart disease

619

1.60

4.81

1.2

1.1

41.64

26.89

u/l

1.21

547

Infliximab

5.28

4.78

1.2

1.1

4.46

31.59

u/l

1.82

Left ventricular outflow tract obstruction (LVOTO), broad definition

163

2.22

4.77

1.2

1.1

55.36

25.84

u/l

0.49

153

Superficial injury of hip and thigh

250

1.97

4.76

1.3

1.1

24.43

26.57

u/l

0.13

232

Spondylopathies

263

1172

1.34

4.73

1.2

1.1

25.07

25.84

u/l

0.05

235

1054

Urticaria and erythema

117

764

1.53

4.72

1.2

1.1

23.82

23.07

u/l

0.06

110

688

Fracture of forearm

185

1210

1.40

4.67

1.1

23.00

25.13

u/l

0.27

163

1095

Gonarthrosis,primary

301

1415

1.31

4.65

1.1

25.98

24.44

u/l

0.13

268

1278

Bacterial, viral and other infectious agents

115

2.45

4.62

1.3

1.1

46.43

22.62

u/l

0.66

109

Keratitis

113

736

1.54

4.62

1.1

19.49

26.73

u/l

1.31

105

662

Ischaemic Stroke, excluding all haemorrhages

181

957

1.41

4.57

1.1

42.66

23.70

u/l

1.42

153

854

Atopic dermatitis, strict definition with reimbursement

472

1.66

4.53

1.2

1.1

14.30

19.64

u/l

0.88

432

Other (seronegative) rheumatoid arthritis, wide

392

1.74

4.53

1.1

21.93

25.65

u/l

0.48

350

Neuralgia and neuritis, unspecified

2.73

4.51

1.0

1.2

23.50

22.28

u/l

0.06

Acute and subacute iridocyclitis

363

1.77

4.50

1.1

21.48

26.43

u/l

0.26

330

Barrett oesophagus

3.17

4.49

1.1

13.00

35.47

u/l

1.84

Abnormal weight loss

155

2.20

4.46

1.0

1.1

19.89

28.36

u/l

0.71

138

Injuries to the ankle and foot

210

1372

1.36

4.44

1.2

1.1

24.52

22.62

u/l

0.17

184

1255

Other external causes of accidental injury

257

962

1.34

4.44

1.1

28.61

22.44

u/l

0.65

228

892

Follow-up examination after treatment for malignant neoplasms

175

2.12

4.43

1.1

17.27

23.45

u/l

0.66

150

Polyp of the female genital tract

114

423

1.55

4.43

1.1

23.48

22.69

u/l

0.05

385

196

2.05

4.37

1.3

1.1

60.20

22.09

u/l

0.65

179

Other hearing loss

529

1.61

4.36

1.2

1.1

35.36

28.96

u/l

0.30

461

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

534

1.61

4.34

1.2

1.1

16.56

21.32

u/l

0.96

494

Other diseases of upper respiratory tract

355

1453

1.27

4.32

1.1

19.62

25.70

u/l

0.93

318

1310

Poisoning by drugs, medicaments and biological substances

413

1.70

4.31

1.2

1.1

18.62

20.86

u/l

0.23

381

Kela reimbursement Agammaglobulinemia (D80-84)

9.08

4.30

1.4

1.1

52.00

14.41

u/l

—

Persons with potential health hazards related to communicable diseases

103

664

1.54

4.27

1.2

1.1

23.09

20.10

u/l

0.21

614

Other neurological diseases

233

1374

1.33

4.26

1.1

28.36

25.17

u/l

0.23

210

1228

Immunodeficiency with predominantly antibody defects

3.89

4.20

1.3

1.1

36.33

29.94

u/l

0.24

Diseases of pulp and periapical tissues and dental caries

206

770

1.37

4.19

1.1

24.61

25.36

u/l

0.06

190

699

External causes of morbidity and mortality

200

728

1.38

4.16

1.2

1.1

25.22

21.78

u/l

0.40

181

666

Somatoform disorder

292

1.82

4.14

1.1

25.15

20.34

u/l

0.20

265

Personality disorders, excluding more controls

411

1.68

4.11

1.2

1.1

35.63

21.12

u/l

0.36

379

Nail disorders

141

2.21

4.11

1.1

47.16

23.16

u/l

0.55

131

Unspecified contracted kidney

10.29

4.04

1.0

1.3

73.71

23.10

u/l

—

Myocardial infarction, unclassifiable

354

1.69

4.02

1.1

57.82

28.96

u/l

1.01

313

Dermatophytosis

238

1.90

4.00

1.1

28.00

27.68

u/l

0.01

218

Symptoms and signs involving cognition, perception, emotional state and behaviour

304

1624

1.28

3.98

1.1

28.28

23.43

u/l

0.58

268

1470

Benign paroxysmal vertigo

651

1.52

3.95

1.1

22.44

26.09

u/l

0.30

580

Malignant neoplasm of digestive organs

105

548

1.51

3.94

1.1

38.07

23.85

u/l

1.32

476

Hernia of abdominal wall

139

978

1.42

3.94

1.2

1.1

29.37

26.30

u/l

0.18

130

873

Inflammatory diseases of female pelvic organs

198

1079

1.35

3.92

1.1

20.98

20.19

u/l

0.10

172

987

L02BB Anti-androgens

144

2.16

3.92

1.3

1.1

37.56

39.94

u/l

0.06

130

Shoulder lesions

236

1083

1.32

3.92

1.2

1.1

24.38

25.02

u/l

0.06

219

969

Sequelae of cerebrovascular disease

113

658

1.48

3.89

1.1

37.33

26.27

u/l

0.79

102

581

Undetermined asthma, excluding more controls

212

1.94

3.89

1.1

16.24

20.86

u/l

0.52

189

Anxiety (asthma-related co-morbidities)

175

987

1.37

3.88

1.1

29.42

20.05

u/l

0.63

164

915

Colectomy operation

328

1.74

3.88

1.2

1.1

30.78

29.47

u/l

0.05

296

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

459

1.62

3.86

1.1

17.34

20.64

u/l

0.38

425

Nonhereditary hypogammaglobulinemia

5.37

3.85

1.3

1.1

40.60

16.62

u/l

—

Trichomoniasis

6.16

3.84

1.2

1.1

22.00

16.93

u/l

—

Trichomoniasis

6.13

3.84

1.2

1.1

22.00

16.93

u/l

—

Superficial injury of lower leg

474

1.61

3.82

1.1

31.59

24.90

u/l

0.27

423

All anxiety disorders

178

1032

1.36

3.82

1.2

1.1

28.93

20.18

u/l

0.59

167

941

Disease of hard tissues of teeth, NOS

173

654

1.39

3.80

1.2

1.1

21.59

28.22

u/l

0.68

154

592

Venous thromboembolism

171

1212

1.36

3.78

1.2

1.1

33.58

24.85

u/l

1.08

160

1077

Iridocyclitis

438

1.63

3.74

1.1

21.11

26.07

u/l

0.30

394

Superficial injury of ankle and foot

174

2.02

3.73

1.2

1.1

23.02

18.08

u/l

0.30

163

Chronic periodontitis, complicated

175

1281

1.36

3.73

1.2

1.1

17.91

25.94

u/l

2.89

157

1158

Other and unspecified nail disorders

3.63

3.71

1.0

1.2

15.21

27.41

u/l

0.89

Operations 2 for CAVS

578

1.53

3.70

1.1

43.44

31.03

u/l

0.41

505

Calcific aortic valvular stenosis, diagnosis (helper)

578

1.53

3.70

1.1

43.44

31.03

u/l

0.41

505

Adenocarcinoma and Papillary adenocarcinoma of kidney

6.78

3.69

1.4

1.3

199.13

41.06

u/l

—

Adjustment and management of implanted device

304

1.75

3.66

1.0

1.1

29.20

28.54

u/l

0.04

263

Calcific aortic valvular stenosis

580

1.52

3.64

1.1

43.44

30.95

u/l

0.42

507

Calcific aortic valvular stenosis, operated

580

1.52

3.64

1.1

43.44

30.95

u/l

0.42

507

Injuries to the knee and lower leg

367

1645

1.24

3.63

1.1

24.31

23.56

u/l

0.08

331

1487

Undetermined asthma

218

1.89

3.61

1.1

16.24

26.42

u/l

1.13

192

Unspecific neurodegenerative disorder

696

0.62

3.57

1.0

1.1

27.25

28.34

u/l

0.07

599

Anterior Iridocyclitis

390

1.65

3.56

1.1

21.48

25.95

u/l

0.23

354

Calcific aortic valvular stenosis, including rheumatic fever

583

1.51

3.55

1.1

43.44

30.93

u/l

0.42

510

Alzheimer disease, including avohilmo

600

0.59

3.52

1.0

1.1

36.36

28.96

u/l

0.34

514

Disorders of iron metabolism

4.29

3.52

1.3

1.2

27.78

17.72

u/l

0.55

Bacterial, viral and other infectious agents

131

2.15

3.51

1.3

1.1

46.43

22.90

u/l

0.65

123

DVT of lower extremities and pulmonary embolism

131

931

1.40

3.47

1.2

1.1

37.12

26.61

u/l

1.03

125

820

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

598

1.51

3.47

1.1

1.2

22.01

25.79

u/l

0.44

547

Glucagon-like peptide-1 (GLP-1) analogues

598

1.51

3.47

1.1

1.2

22.01

25.79

u/l

0.44

547

Alzheimer disease

517

0.55

3.46

1.1

43.87

29.85

u/l

0.56

448

Benign neoplasm: Colon, unspecified

519

1.55

3.44

1.2

1.1

36.32

28.75

u/l

0.52

457

Accidents

248

962

1.29

3.44

1.1

29.37

22.44

u/l

0.74

222

892

Primary coxarthrosis, bilateral

633

1.49

3.41

1.2

1.1

23.24

28.10

u/l

0.40

560

Excessive earwax

168

1222

1.34

3.40

1.1

24.88

24.74

u/l

0.01

150

1089

Ventral hernia

497

1.55

3.40

1.2

1.1

28.06

26.09

u/l

0.10

438

Other malignant neoplasms of skin (=non-melanoma skin cancer)

128

621

1.42

3.38

1.2

1.1

26.96

23.69

u/l

0.30

116

538

Fracture of foot, except ankle

466

1.57

3.38

1.2

1.1

19.87

20.30

u/l

0.04

426

Pain associated with micturition

203

1.88

3.33

1.3

1.1

11.59

25.40

u/l

3.97

186

Degenerative diseases of the nervous system

597

0.59

3.33

1.0

1.1

39.90

29.51

u/l

0.49

517

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

136

662

1.40

3.32

1.2

1.1

26.27

23.66

u/l

0.25

123

573

Artificial joint operation, meniscal resection

291

1509

1.25

3.31

1.1

21.15

25.90

u/l

1.10

258

1363

Open wound of wrist and hand

121

840

1.41

3.31

1.1

27.45

26.52

u/l

0.05

107

764

Haemorrhoids and perianal venous thrombosis

669

1.46

3.29

1.2

1.1

25.57

26.03

u/l

0.03

598

Asthma-related pneumonia

110

768

1.43

3.28

1.1

28.39

26.39

u/l

0.14

102

677

Factitial dermatitis

8.80

3.28

1.2

1.1

19.67

25.71

u/l

—

Common variable immunodeficiency

8.76

3.28

1.5

1.1

66.33

17.24

u/l

—

547

1.48

3.27

1.2

1.1

26.69

28.75

u/l

0.17

478

Asthma, hospital admissions 3, pneumonia

110

770

1.43

3.24

1.1

28.39

26.36

u/l

0.14

102

679

Asthma-related pneumonia or sepsis

110

770

1.43

3.24

1.1

28.39

26.36

u/l

0.14

102

679

Obesity, other/unspecified

101

698

1.45

3.23

1.1

17.93

23.03

u/l

1.00

639

Diseases of inner ear

173

1265

1.32

3.20

1.1

22.93

26.32

u/l

0.37

160

1128

Excessive attrition of teeth

165

1240

1.33

3.20

1.1

18.36

24.37

u/l

1.60

147

1133

Disorder of pancreatic internal secretion, other and/or unspecified

6.50

3.20

1.0

1.2

29.14

7.15

u/l

—

Vitamin D deficiency

4.21

3.20

1.2

1.1

39.60

25.30

u/l

—

Diseases of middle ear and mastoid

154

933

1.35

3.20

1.1

32.78

23.76

u/l

0.68

146

845

Disorders of vestibular function (Vertigo)

150

1093

1.35

3.19

1.1

24.27

25.07

u/l

0.06

139

976

Other and unspecified disorders of vitreous body

140

1012

1.37

3.19

1.2

1.1

21.37

26.24

u/l

0.57

129

903

Status epilepticus

2.87

3.19

1.1

24.93

32.93

u/l

0.31

Duodenal ulcer

171

1.94

3.18

1.1

23.81

37.71

u/l

0.79

153

Basal cell carcinoma

122

600

1.41

3.18

1.2

1.1

26.97

22.80

u/l

0.38

113

519

Asthma, hospital admission 2, infections

175

1300

1.32

3.17

1.1

25.21

25.64

u/l

0.04

162

1159

Asthma-related infections

175

1300

1.32

3.17

1.1

25.21

25.64

u/l

0.04

162

1159

Open wound of forearm

137

2.05

3.16

1.3

1.1

22.41

27.00

u/l

0.29

123

Infections with a predominantly sexual mode of transmission

102

661

1.44

3.13

1.2

1.1

33.87

17.14

u/l

1.16

616

Dorsopathies

310

1272

1.24

3.10

1.1

21.81

24.90

u/l

0.50

282

1147

Other headache syndromes

125

904

1.38

3.10

1.1

20.72

22.95

u/l

0.30

118

816

Obesity related asthma

106

746

1.42

3.09

1.1

17.55

27.11

u/l

2.23

670

Microscopic polyangiitis

7.68

3.07

1.5

1.1

8.50

34.88

u/l

—

Other bacterial agents as the cause of diseases classified to other chapters

5.08

3.06

1.4

1.1

33.63

39.17

u/l

—

Benign intracranial hypertension

7.59

3.06

1.2

1.0

8.83

38.09

u/l

—

Striking against or struck by other objects

583

1.48

3.04

1.2

1.1

35.07

24.92

u/l

0.51

532

Mental and behavioural disorders due to alcohol

140

995

1.35

3.03

1.1

44.98

22.89

u/l

1.22

119

908

Other viral diseases, not elsewhere classified

291

1.68

3.02

1.1

25.97

25.50

u/l

0.03

267

Unspecified fall

146

1072

1.34

3.02

1.2

1.1

29.13

25.85

u/l

0.22

129

963

Malignant neoplasm of penis, including Hilmo

10.18

2.99

1.0

1.2

7.80

86.20

u/l

—

Atopic dermatitis

157

967

1.33

2.99

1.2

1.1

14.33

22.68

u/l

2.86

148

875

Other extrapyramidal and movement disorders in other diseases

505

1.51

2.99

1.1

18.45

26.81

u/l

1.39

453

Injuries to the wrist and hand

299

1683

1.23

2.98

1.1

25.78

23.34

u/l

0.26

268

1524

Fall on same level involving ice and snow

174

1335

1.31

2.95

1.1

26.27

25.24

u/l

0.07

152

1212

Alzheimer’s disease (Late onset)

388

0.50

2.92

1.0

1.1

46.11

30.56

u/l

0.33

330

Alzheimer’s disease, strict definition

423

0.52

2.90

1.0

1.1

43.55

29.76

u/l

0.36

365

Benign neoplasm: Descending colon

115

2.10

2.88

1.3

1.1

30.04

30.31

u/l

0.01

102

Basal cell carcinoma, including avohilmo

126

633

1.37

2.86

1.2

1.1

25.26

23.46

u/l

0.15

116

547

Disorder of lipoprotein metabolism, unspecified

229

1.75

2.86

1.1

33.41

27.74

u/l

0.23

207

Other inflammation of eyelid

259

1.70

2.86

1.2

1.1

14.36

26.40

u/l

2.15

237

Myelodysplastic syndrome, including Hilmo

3.18

2.85

1.1

55.50

27.74

u/l

0.38

Specific personality disorders

399

1.56

2.83

1.2

1.1

37.69

20.29

u/l

0.37

370

126

850

1.36

2.83

1.2

1.1

26.09

26.53

u/l

0.04

116

739

Granulomatous disorders of skin and subcutaneous tissue

3.36

2.81

1.1

14.82

31.09

u/l

1.02

Other specified/unspecified necrotizing vasculopathies

4.50

2.80

1.1

23.38

40.76

u/l

—

Respiratory conditions due to other external agents

3.60

2.79

1.4

1.1

25.00

32.89

u/l

—

Actinic keratosis

117

790

1.37

2.79

1.2

1.1

27.79

26.29

u/l

0.16

107

685

Hyperplasia of prostate

355

1.46

2.79

1.1

1.2

18.73

33.08

u/l

2.12

319

Chronic hepatitis NAS

3.97

2.78

1.1

50.33

34.22

u/l

—

Melanocytic naevi, other sites/unspecified

124

2.02

2.75

1.3

1.1

17.84

23.08

u/l

0.39

116

Artrosis, including avohilmo

252

1109

1.24

2.71

1.1

20.50

25.78

u/l

1.08

228

1013

Hypertrophy of breast

388

1.55

2.70

1.1

12.33

19.47

u/l

2.32

353

Epilepsy

590

1.44

2.68

1.2

1.1

26.77

25.76

u/l

0.05

521

Speech and linguistic disorders, excluding more controls

2.29

2.66

1.1

15.32

18.89

u/l

0.20

Polycythaemia vera

2.67

2.62

1.0

1.1

33.23

24.23

u/l

0.28

Urolithiasis

645

1.41

2.61

1.1

20.99

29.26

u/l

1.04

576

Provisional assignment of new diseases of uncertain etiology

152

1165

1.30

2.61

1.2

1.1

31.36

23.99

u/l

0.92

143

1037

Glaucoma

177

1190

1.28

2.61

1.2

1.1

20.97

26.71

u/l

1.19

149

1069

Spinal stenosis

163

955

1.30

2.60

1.2

1.1

24.06

26.23

u/l

0.23

146

854

Other bursopathies

244

1.68

2.59

1.3

1.1

18.34

25.52

u/l

0.93

216

Early onset COPD

457

1.49

2.58

1.1

21.17

31.19

u/l

1.18

412

Other bacterial agents as the cause of diseases classified to other chapters

4.05

2.58

1.4

1.1

33.63

33.69

u/l

—

Other diseases of lip and oral mucosa

122

910

1.34

2.58

1.2

1.1

22.51

24.22

u/l

0.22

105

825

Hypertrophy of breast in women and men

433

1.50

2.57

1.1

12.15

21.43

u/l

3.65

395

Other and unspecified trigeminal disorders

4.04

2.57

1.4

1.3

8.88

23.64

u/l

—

Urticaria

597

1.43

2.57

1.2

1.1

26.79

22.45

u/l

0.34

541

Codes for special purposes

152

1168

1.30

2.57

1.2

1.1

31.36

23.98

u/l

0.92

143

1038

COPD

133

819

1.33

2.56

1.2

1.1

22.86

28.54

u/l

0.79

114

719

Disorders of breast

155

1085

1.30

2.56

1.1

16.55

21.29

u/l

0.89

141

983

Cystic disease of liver

5.56

2.56

1.5

1.1

42.48

29.09

u/l

—

Carcinoid syndrome

5.53

2.55

1.2

141.83

45.88

u/l

—

Severe visual impairment, monocular

5.53

2.55

1.0

1.1

27.00

44.06

u/l

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

192

1.77

2.55

1.1

24.14

25.79

u/l

0.10

165

Calculus of kidney and ureter

599

1.42

2.53

1.1

21.86

30.12

u/l

0.95

537

Skin changes due to chronic exposure to nonionizing radiation

119

817

1.35

2.52

1.2

1.1

27.37

26.89

u/l

0.04

109

710

Fracture of lower leg, including ankle

166

1283

1.28

2.52

1.1

29.06

25.27

u/l

0.23

146

1155

Visual disturbances and blindness

153

1182

1.30

2.52

1.2

1.1

25.96

24.03

u/l

0.09

138

1059

Other viral diseases

508

1.45

2.50

1.1

25.43

21.83

u/l

0.34

463

Other dorsopathies, not elsewhere classified

294

1269

1.21

2.50

1.2

1.1

21.29

24.95

u/l

0.70

268

1144

Cytomegalovirus infection, IBD co-morbidity

3.00

2.49

1.1

25.45

23.26

u/l

0.07

Personality disorders

469

1.47

2.49

1.2

1.1

35.63

19.78

u/l

0.40

438

Use of other anti-dementia drugs

467

0.58

2.49

1.0

1.1

30.93

31.21

u/l

0.01

402

Use of memantine

467

0.58

2.49

1.0

1.1

30.93

31.21

u/l

0.01

402

Conjunctivitis

217

1460

1.24

2.48

1.2

1.1

21.89

24.17

u/l

0.26

202

1321

Wet age-related macular degeneration

323

1.56

2.46

1.1

24.79

32.43

u/l

0.70

285

388

1.51

2.46

1.2

1.1

27.13

31.05

u/l

0.29

343

Female genital prolapse

101

411

1.39

2.45

1.1

17.48

23.10

u/l

0.87

373

Temporomandibular joint disorders, including avohilmo

123

913

1.33

2.45

1.2

1.1

25.23

20.49

u/l

0.40

107

838

Mental and behavioural disorders due to alcohol, excluding acute intoxication

119

888

1.34

2.44

1.1

46.08

23.95

u/l

0.95

809

Other renal tubulo-interstitial diseases

3.15

2.44

1.1

24.00

22.69

u/l

—

Carpal tunnel syndrome

189

1326

1.26

2.43

1.1

28.30

23.95

u/l

0.41

172

1195

122

912

1.33

2.42

1.1

22.75

25.37

u/l

0.27

113

818

Other chondrocalcinosis

5.05

2.41

1.0

1.2

61.17

40.81

u/l

—

Alcoholic gastritis

5.04

2.40

1.2

1.5

16.73

32.50

u/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

117

1.98

2.40

1.1

17.28

23.52

u/l

0.57

108

Irregular menses

141

854

1.31

2.40

1.2

1.1

16.48

18.22

u/l

0.22

131

786

Delirium, not induced by alcohol and other psychoactive substances

204

1.72

2.38

1.2

1.1

19.77

30.84

u/l

1.15

186

Hydrocephalus in other diseases

6.37

2.38

1.0

1.1

36.40

19.12

u/l

—

Explicit fungal Sepsis

6.35

2.38

1.0

102.60

52.12

u/l

—

Flatulence and related conditions

6.31

2.38

1.0

1.3

15.40

35.25

u/l

—

Symptoms and signs involving speech and voice

100

734

1.36

2.37

1.1

18.04

25.67

u/l

1.51

658

Spontaneous rupture of synovium and tendon

146

1.86

2.37

1.0

1.1

39.59

29.36

u/l

0.21

133

Other chronic obstructive pulmonary disease

128

801

1.32

2.36

1.2

1.1

21.03

28.95

u/l

1.49

110

705

Other/unspecified cytomegaloviral diseases

3.06

2.36

1.1

26.40

29.78

u/l

—

Menorrhagia

109

444

1.36

2.36

1.2

1.1

16.85

22.08

u/l

1.02

100

406

Asthma (diagnoses ohter than nonallergic)

255

1744

1.21

2.35

1.1

20.56

24.74

u/l

0.85

235

1569

Dental pulpitis, including avohilmo

264

1413

1.21

2.35

1.1

19.11

24.33

u/l

1.29

239

1292

Polyuria

418

1.49

2.35

1.1

16.95

26.70

u/l

2.17

372

Behavioural syndromes associated with physiological disturbances and physical factors

269

1580

1.21

2.32

1.2

1.1

22.45

24.40

u/l

0.22

245

1429

Acute nephritic syndrome

3.24

2.31

1.1

18.92

25.17

u/l

—

Systemic lupus erythematosus

2.39

2.29

1.0

1.1

20.00

27.11

u/l

0.42

Abscess of external ear

3.51

2.27

1.1

13.38

31.82

u/l

—

Acquired absence of organs, not elsewhere classified

3.93

2.26

1.1

1.2

16.00

31.37

u/l

—

Cerebral cysts

2.16

2.24

1.1

26.65

27.00

u/l

0.01

Sulfonylureas

102

601

1.35

2.24

1.1

37.34

26.39

u/l

0.82

525

Diseases of salivary glands

699

1.36

2.24

1.1

31.05

23.36

u/l

0.35

629

Fracture at wrist and hand level

647

1.37

2.23

1.1

31.41

26.27

u/l

0.22

589

Autoimmune hepatitis

5.62

2.22

1.0

30.40

43.56

u/l

—

Diplopia

240

1.63

2.21

1.2

1.1

16.97

27.65

u/l

1.43

219

Acute alcohol intoxication, ICD10

327

1.53

2.20

1.1

28.59

29.83

u/l

0.06

305

Postmenopausal bleeding

383

1.37

2.17

1.2

1.1

18.73

23.88

u/l

0.78

347

N06DA Anticholinesterases

618

0.68

2.16

1.0

1.1

38.20

28.76

u/l

0.45

536

Use of anticholinesterases

618

0.68

2.16

1.0

1.1

38.20

28.76

u/l

0.45

536

Intracerebral haemorrhage

211

1.66

2.15

1.3

1.1

44.13

23.80

u/l

0.54

190

Acquired haemolytic anaemia

3.02

2.15

1.1

38.11

29.13

u/l

—

Spirochaetal infections, other/unspecified

166

1.75

2.15

1.2

1.1

15.79

24.60

u/l

1.28

150

Alcohol use disorder, ICD-based

109

825

1.32

2.15

1.1

48.35

24.30

u/l

0.94

750

Diseases of male genital organs

117

445

1.33

2.13

1.1

1.2

29.06

32.21

u/l

0.17

107

402

Asthma, including avohilmo

349

1672

1.17

2.12

1.1

19.33

25.04

u/l

1.62

327

1502

Other hammer toe(s) (acquired)

342

1.49

2.10

1.1

20.55

23.00

u/l

0.26

304

Cytomegaloviral disease

2.58

2.08

1.1

25.45

29.65

u/l

0.15

Erosion of teeth , including avohilmo

438

1.44

2.08

1.1

22.10

23.49

u/l

0.09

402

Hodgkin lymphoma, hilmo

2.57

2.08

1.1

53.64

26.46

u/l

0.72

Atopic dermatitis, strict definition

494

1.41

2.08

1.2

1.1

15.19

18.19

u/l

0.38

455

Lymphangioma, anys site

5.06

2.08

1.0

1.2

15.40

32.67

u/l

—

Procreative management

553

1.36

2.08

1.2

1.1

21.20

19.62

u/l

0.13

505

Congenital malformations of gallbladder, bile ducts and liver

4.05

2.04

1.5

1.1

42.48

23.60

u/l

—

Triptan medication for migraine, single purchase ok

218

1216

1.21

2.04

1.1

20.48

24.33

u/l

0.53

205

1106

Migraine, single triptan purchase ok & required. ICD-code if available is included

218

1216

1.21

2.04

1.1

20.48

24.33

u/l

0.53

205

1106

FESS (DNB20)

215

1.63

2.02

1.1

25.26

22.63

u/l

0.11

200

SLE, strict definition

2.24

2.01

1.0

1.1

20.00

28.10

u/l

0.51

SLE, ICD10

2.24

2.01

1.0

1.1

20.00

28.10

u/l

0.51

Cardiomyopathy

279

1.54

1.99

1.1

23.03

25.98

u/l

0.23

247

Disorders of adult personality and behaviour

501

1.40

1.99

1.2

1.1

34.39

20.46

u/l

0.33

465

Nontraumatic intracranial haemmorrhage

393

1.45

1.98

1.2

1.1

39.57

25.91

u/l

0.58

354

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.59

1.94

1.0

1.2

34.60

16.91

u/l

—

Persistent mood disorders

362

1.47

1.94

1.2

1.1

19.26

26.64

u/l

0.76

328

Other symptoms and signs involving cognitive functions and awareness

135

971

1.27

1.94

1.1

33.02

24.62

u/l

0.63

118

867

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

146

1133

1.25

1.92

1.1

21.61

25.06

u/l

0.17

130

1023

Other chronic obstructive pulmonary disease, including avohilmo

154

1021

1.25

1.92

1.2

1.1

20.75

27.15

u/l

1.43

134

909

Sleep disorders

255

1553

1.19

1.90

1.2

1.1

22.67

24.60

u/l

0.21

232

1406

Ovarian cyst

105

460

1.32

1.90

1.1

18.35

21.25

u/l

0.37

422

Benign neoplasm of eye and adnexa

188

1.65

1.90

1.1

44.48

24.99

u/l

0.50

171

Other intervertebral disc disorders

241

1214

1.20

1.90

1.2

1.1

20.87

25.22

u/l

0.82

223

1095

Coxarthrosis, primary, with hip surgery

143

1068

1.25

1.90

1.1

22.79

26.55

u/l

0.44

128

949

Cardiodefibrillation

100

762

1.31

1.89

1.1

29.14

30.48

u/l

0.07

675

Non-follicular lymphoma

158

1.71

1.88

1.1

31.52

30.63

u/l

0.04

142

Granuloma annulare

3.21

1.88

1.0

14.00

37.14

u/l

—

Benign neoplasm: Small intestine

2.16

1.88

1.1

22.78

23.56

u/l

—

Peritonsillar abscess

340

1.47

1.88

1.1

21.00

24.04

u/l

0.25

311

Coronary artery bypass grafting

375

1.39

1.87

1.2

1.1

38.23

26.42

u/l

0.56

329

Vasomotor and allergic rhinitis

101

759

1.31

1.87

1.1

17.44

23.60

u/l

0.90

690

Allergic contact dermatitis due to drugs in contact with skin

2.66

1.87

1.2

1.1

16.41

26.41

u/l

—

Myocardial infarction, with ST-elevation

300

1.50

1.86

1.1

22.46

33.13

u/l

1.00

267

Schizophrenia or delusion, excluding more controls

520

1.37

1.85

1.2

1.1

16.19

22.43

u/l

1.08

480

Systemic sclerosis,strict definition

3.57

1.84

1.2

1.1

12.17

15.81

u/l

—

Lifestyle-related condition

3.56

1.84

1.0

1.1

19.17

30.11

u/l

—

Injury of eye and orbit

221

1.59

1.84

1.1

83.30

25.25

u/l

0.79

206

Unspecified mental disorder

105

811

1.30

1.83

1.2

1.1

15.47

25.90

u/l

2.60

746

COPD, early/later onset

129

861

1.26

1.82

1.2

1.1

21.09

28.96

u/l

1.55

111

762

Ethmoidectomy

222

1.58

1.81

1.1

25.26

23.97

u/l

0.05

206

Coxarthrosis, primary

180

1253

1.22

1.81

1.1

22.20

27.32

u/l

0.80

160

1116

Certain conditions originating in the perinatal period

1.90

1.80

1.2

1.1

16.34

18.90

u/l

0.17

Dentofacial anomalies [including malocclusion]

193

1283

1.21

1.80

1.2

1.1

20.94

23.46

u/l

0.28

171

1178

Superficial injury of abdomen, lower back and pelvis

239

1.55

1.78

1.1

18.48

25.67

u/l

0.81

217

Other and unspecified types of non-Hodgkin lymphoma, hilmo

2.18

1.78

1.1

1.2

59.69

24.39

u/l

0.50

COPD related to multimorbidity

111

732

1.28

1.76

1.2

1.1

21.45

29.51

u/l

1.55

642

Postmenopausal atrophic vaginitis

383

1.33

1.76

1.1

19.02

23.26

u/l

0.48

346

Stomatitis and related lesions

362

1.44

1.76

1.1

16.27

24.37

u/l

1.45

328

COPD, hospital admissions

127

853

1.26

1.75

1.2

1.1

21.23

28.97

u/l

1.49

110

753

Other anxiety disorders

112

760

1.28

1.75

1.2

1.1

33.98

19.49

u/l

0.66

105

697

Delivery, wide proxy

419

0.71

1.74

1.2

1.1

21.10

26.78

u/l

0.44

369

Acute lymphadenitis

1.98

1.74

1.3

1.1

74.06

25.04

u/l

0.60

Non-Hodgkin lymphoma, all

2.23

1.74

1.1

52.31

30.04

u/l

0.45

Background retinopathy and retinal vascular changes

2.68

1.72

1.6

1.1

9.88

35.49

u/l

—

Endometriosis of intestine

3.87

1.72

1.0

1.2

100.60

18.77

u/l

—

Later onset COPD, excluding more controls

305

1.42

1.71

1.2

1.1

21.60

26.88

u/l

0.51

255

Fall on and from stairs and steps

516

1.36

1.71

1.1

19.62

26.36

u/l

0.98

463

Malignant neoplasm of stomach, including Hilmo

1.96

1.69

1.1

25.42

28.70

u/l

0.11

Fracture of skull and facial bones

357

1.43

1.68

1.2

1.1

35.59

23.07

u/l

0.52

330

Kela-code for severe mental illness

717

1.30

1.68

1.1

16.09

26.29

u/l

2.14

660

Transient ischemic attack

149

981

1.23

1.68

1.1

31.74

23.61

u/l

0.46

132

879

Fracture of shoulder and upper arm

769

1.29

1.68

1.2

1.1

30.16

26.65

u/l

0.17

687

Other female pelvic inflammatory diseases

341

1.44

1.67

1.2

22.98

19.63

u/l

0.15

312

Other autoimmune haemolytic anaemias

3.19

1.66

1.2

1.1

44.00

39.46

u/l

—

Other diseases of appendix

2.83

1.65

1.0

1.1

18.70

17.84

u/l

—

Migraine

128

832

1.25

1.65

1.2

1.1

16.61

20.36

u/l

0.78

122

750

Primary open-angle glaucoma

695

1.30

1.65

1.2

1.1

17.55

27.68

u/l

2.81

614

Other/unspecified dorsalgia

108

845

1.27

1.63

1.2

1.1

19.47

24.34

u/l

0.68

754

Enthesopathies of lower limb, excluding foot

478

1.36

1.63

1.2

1.1

26.36

25.70

u/l

0.03

433

Traction detachment of retina

3.61

1.62

1.0

1.1

14.40

48.19

u/l

—

Thyrotoxicosis with toxic single thyroid nodule

3.61

1.62

1.2

1.1

6.80

16.36

u/l

—

Malignant immunoproliferative diseases

3.61

1.62

1.2

1.1

31.40

43.76

u/l

—

Other viral diseases

681

1.30

1.62

1.1

23.57

21.92

u/l

0.15

624

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

149

1189

1.22

1.59

1.2

1.1

22.96

21.80

u/l

0.09

140

1078

Polyarteritis nodosa and related conditions

3.02

1.58

1.2

1.1

27.33

16.44

u/l

—

Injuries to the neck

404

1.39

1.58

1.1

16.15

24.64

u/l

1.43

372

Retinal detachments and breaks

769

1.28

1.57

1.1

22.80

24.29

u/l

0.11

680

Other arthrosis

145

820

1.23

1.56

1.1

24.62

24.36

u/l

0.03

133

740

Speech and linguistic disorders

1.82

1.56

1.1

15.32

22.84

u/l

0.49

Small cell lung cancer, including Hilmo

2.60

1.51

1.0

1.1

46.86

29.53

u/l

—

Small cell lung cancer

2.60

1.51

1.0

1.1

46.86

29.53

u/l

—

Mixed conductive and sensorineural hearing loss

225

1.51

1.1

22.24

27.25

u/l

0.30

199

Other factor of the environment

2.88

1.51

1.0

19.17

23.99

u/l

—

Fistulae involving female genital tract

2.87

1.51

1.0

1.2

46.33

21.05

u/l

—

Use of pramipexole

468

1.35

1.50

1.1

20.24

27.60

u/l

0.88

416

Hernia

271

1575

1.15

1.48

1.1

29.33

24.40

u/l

0.58

247

1418

Primary open-angle glaucoma, strict

598

1.30

1.48

1.2

1.1

17.90

27.33

u/l

2.16

530

Rare circulating lymphoid malignancy, including Hilmo

2.44

1.48

1.1

38.56

25.05

u/l

—

Herpesviral [herpes simplex] infections

470

1.34

1.47

1.1

24.57

22.20

u/l

0.20

430

Cardiomyopathy, other and unspecified

109

1.75

1.46

1.0

1.1

21.15

29.89

u/l

0.40

102

Visual disturbances

134

1101

1.22

1.45

1.2

1.1

27.15

24.42

u/l

0.12

119

990

Vitiligo

3.15

1.44

1.2

1.1

10.40

33.76

u/l

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.15

1.44

1.2

1.1

47.00

30.23

u/l

—

Donors of organs and tissues

2.74

1.43

1.2

1.1

42.50

22.76

u/l

—

Diffuse large B-cell lymphoma, helper endpoint

1.98

1.43

1.1

45.15

27.04

u/l

0.82

Diffuse large B-cell lymphoma, including Hilmo

1.98

1.43

1.1

45.15

27.04

u/l

0.82

Diffuse large B-cell lymphoma

1.98

1.43

1.1

45.15

27.04

u/l

0.82

Sciatica+with lumbago

145

1106

1.21

1.43

1.1

17.73

25.71

u/l

1.52

133

1000

Disorders of ocular muscles, binocular movement, accommodation and refraction

122

987

1.23

1.42

1.1

18.23

24.23

u/l

0.94

112

897

Benign neoplasm: Rectum, anus and anal canal

414

1.35

1.40

1.2

1.1

18.26

28.13

u/l

1.67

372

Excessive, frequent and irregular menstruation

107

468

1.25

1.40

1.2

1.1

12.88

21.22

u/l

2.38

429

Allergic conjunctivitis

155

1264

1.20

1.39

1.2

1.1

22.46

21.33

u/l

0.09

145

1149

Insomnia

243

1533

1.16

1.39

1.2

1.1

22.71

24.36

u/l

0.17

220

1389

Disorder of the sleep-wake schedule

2.43

1.39

1.4

1.1

5.70

33.38

u/l

—

Injury, poisoning and certain other consequences of external causes

147

609

1.21

1.37

1.2

1.1

23.22

21.08

u/l

0.24

135

556

Complications following infusion, transfusion and therapeutic injection

2.63

1.37

1.0

1.1

14.17

40.77

u/l

—

Other prurigo

2.96

1.36

1.0

1.1

9.00

46.36

u/l

—

Phakomatoses, not elsewhere classified

2.96

1.36

1.2

1.1

51.38

31.39

u/l

—

Injuries to the shoulder and upper arm

238

1664

1.15

1.35

1.2

1.1

27.20

24.65

u/l

0.22

213

1500

Other disorders of veins

120

980

1.22

1.33

1.1

22.12

24.40

u/l

0.25

106

888

Nontoxic multinodular goitre

418

1.34

1.33

1.1

16.84

25.03

u/l

1.72

374

Haemorrhage in early pregnancy

611

0.73

1.32

1.1

19.66

18.34

u/l

0.06

566

Conjunctivitis (acute, non atopic)

521

1.30

1.32

1.2

1.1

21.30

24.50

u/l

0.30

469

Melanocytic naevi

611

1.28

1.32

1.3

1.1

19.89

24.28

u/l

0.53

558

Non-allergic asthma

147

0.47

1.31

1.0

1.1

14.71

25.79

u/l

—

131

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.51

1.30

1.3

1.0

23.83

23.41

u/l

—

Other enthesopathies

648

1.27

1.29

1.2

1.1

19.93

24.67

u/l

0.38

585

Diaphragmatic hernia

102

827

1.23

1.29

1.1

21.66

25.09

u/l

0.44

734

Other nonscarring hair loss

2.80

1.29

1.0

1.3

86.60

36.28

u/l

—

Arthropathy in Crohn disease

2.80

1.29

1.0

1.1

11.60

24.34

u/l

—

Ulcer of oesophagus

1.76

1.29

1.2

1.1

17.63

36.51

u/l

1.69

Rotator cuff syndrome

170

1035

1.18

1.28

1.2

1.1

21.84

25.60

u/l

0.49

159

926

Fibroblastic disorders

473

1.31

1.28

1.1

26.76

29.69

u/l

0.12

417

Fourth [trochlear] nerve palsy

2.06

1.27

1.1

40.44

27.38

u/l

—

Papilloedema, unspecified

2.30

1.27

1.3

1.1

55.25

29.13

u/l

—

Angina pectoris

153

858

1.19

1.26

1.1

32.58

22.61

u/l

0.85

142

761

Other viral diseases, not elsewhere classified

454

1.32

1.26

1.1

23.12

22.37

u/l

0.06

416

Extrapyramidal and movement disorders

103

839

1.23

1.26

1.1

18.55

26.02

u/l

1.66

748

Toxic liver disease

2.41

1.24

1.0

69.50

27.91

u/l

—

Leiomyoma of uterus

192

934

1.17

1.23

1.2

1.1

23.27

20.58

u/l

0.32

176

843

Unspecified/other endometriosis

131

1.61

1.23

1.1

1.2

20.09

15.59

u/l

0.37

125

Any dementia

643

0.79

1.22

1.1

28.55

29.38

u/l

0.05

555

Secondary thrombocytopenia

2.65

1.22

1.2

1.1

10.80

35.35

u/l

—

Family history of other specific disorders

2.65

1.22

1.2

1.1

9.60

29.98

u/l

—

Secondary polycythaemia

2.17

1.21

1.1

1.2

35.08

24.08

u/l

—

Strabismus

504

1.29

1.19

1.1

18.96

23.20

u/l

0.37

459

Essential (haemorrhagic) thrombocythaemia

1.94

1.17

1.3

1.1

46.47

21.46

u/l

0.94

Poisoning by medicine, drug-induced

0.00

1.16

0.0

1.2

—

34.24

—

Specific development disorders of speech and language

1.87

1.15

1.2

1.1

18.75

25.16

u/l

0.25

Single spontaneous delivery

522

0.80

1.13

1.1

1.2

18.15

26.16

u/l

1.12

467

Malignant neoplasm of stomach

1.85

1.13

1.1

28.56

28.40

u/l

0.00

Acetic acid derivatives and related substances

289

1.28

1.12

1.1

1.2

34.58

28.56

u/l

0.21

258

Benign neoplasm: Skin of other and unspecified parts of face

192

1.46

1.11

1.1

13.17

28.08

u/l

3.17

174

Dizziness and giddiness

213

1480

1.14

1.10

1.1

30.53

23.80

u/l

0.65

188

1339

Certain zoonotic bacterial diseases

2.27

1.10

1.0

1.1

25.00

32.77

u/l

—

Pregnancy hypertension

112

837

1.20

1.10

1.1

1.2

18.44

18.25

u/l

0.02

106

765

Ankylosing hyperostosis [Forestier]

2.39

1.09

1.0

1.2

6.80

30.77

u/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.39

1.09

1.0

13.00

22.80

u/l

—

Family history of other conditions

2.39

1.09

1.0

1.1

19.40

33.56

u/l

—

Spondylosis

156

1093

1.16

1.07

1.2

1.1

26.05

26.25

u/l

0.01

132

981

Other secondary gonarthrosis

1.69

1.07

1.3

1.1

21.80

20.79

u/l

0.05

Alcohol dependence

487

1.27

1.07

1.1

64.66

25.66

u/l

0.82

442

Benign neoplasm: Sigmoid colon

399

1.31

1.07

1.3

1.1

26.65

30.05

u/l

0.13

362

Caries of enamel

240

1533

1.13

1.06

1.2

1.1

19.62

24.58

u/l

0.74

216

1397

Asthma/COPD (KELA code 203)

258

1573

1.12

1.06

1.1

15.85

24.82

u/l

4.92

237

1420

Mental disorders, not otherwise specified

113

1.60

1.05

1.3

1.1

11.66

21.92

u/l

1.53

108

Schizophrenia, schizotypal and delusional disorders

587

1.24

1.05

1.2

1.1

16.14

22.80

u/l

1.19

537

Transport accidents

114

824

1.19

1.04

1.2

1.1

29.66

22.00

u/l

0.51

103

767

Blepharochalasis

714

1.22

1.04

1.1

19.81

26.50

u/l

0.87

643

Combinations of oral blood glucose lowering drugs

570

1.25

1.04

1.0

1.1

24.60

27.39

u/l

0.22

506

Benign neoplasm: Parathyroid gland

2.29

1.03

1.2

1.1

6.60

28.19

u/l

—

Other lack of coordination

2.28

1.03

1.2

1.1

8.60

33.58

u/l

—

Disorders of refraction and accommodation

497

1.26

1.03

1.1

16.49

22.74

u/l

0.79

451

Disorders of optic nerve, not elsewhere classified

2.07

1.03

1.1

12.79

32.88

u/l

—

Complications of other internal prosthetic devices, implants and grafts

1.84

1.03

1.2

1.1

23.64

27.19

u/l

0.10

Adhesive capsulitis of shoulder

341

1.32

1.02

1.3

1.1

13.28

25.59

u/l

2.44

308

Other disorders of eyelid

128

1038

1.17

1.02

1.1

18.64

26.74

u/l

1.89

114

926

Hallux rigidus

281

1.35

1.01

1.1

19.43

26.02

u/l

0.51

247

Pterygium

1.89

1.01

1.1

17.00

28.25

u/l

—

Sequelae of other external causes

1.65

1.00

1.2

1.1

69.07

23.95

u/l

0.68

Varicose veins

184

1216

1.14

1.00

1.1

21.43

25.34

u/l

0.58

163

1093

Dermatophytosis

158

1370

1.15

1.00

1.1

23.25

23.41

u/l

0.01

139

1235

Schizophrenia or delusion

582

1.24

1.00

1.2

1.1

16.19

22.90

u/l

1.18

532

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

125

926

1.17

0.99

1.1

1.2

17.84

19.43

u/l

0.20

118

848

Salpingitis and oophoritis

431

1.28

0.99

1.1

1.2

27.89

20.29

u/l

0.39

397

Periapical abscess

1059

0.83

0.98

1.1

27.11

25.81

u/l

0.05

961

Tularaemia

2.19

0.98

1.0

1.1

32.60

36.26

u/l

—

Other and unspecified haemorrhagic conditions

2.18

0.98

1.6

1.1

45.20

27.30

u/l

—

Nontoxic goitre/thyroid nodule

683

1.22

0.98

1.1

16.95

22.89

u/l

1.52

615

Aortic aneurysm

406

1.28

0.98

1.1

27.21

25.04

u/l

0.14

353

Toxic effect of alcohol

1.95

0.97

1.3

1.1

102.14

29.38

u/l

—

Post-traumatic wound infection, not elsewhere classified

1.95

0.97

1.0

1.1

47.14

28.77

u/l

—

Other specified/unspecified disorders of bone/cartilage

1.95

0.97

1.0

1.1

15.57

19.61

u/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

460

1.25

0.96

1.3

1.1

21.65

31.16

u/l

1.22

406

Right hemicolectomy

100

1.60

0.96

1.3

1.1

56.00

30.75

u/l

0.41

Hydrocele

190

1.42

0.96

1.1

19.86

37.23

u/l

1.30

167

Hypermetropia

100

1.60

0.96

1.1

14.81

23.08

u/l

0.90

Pregnancy, childbirth and the puerperium

359

0.78

0.96

1.1

1.2

26.17

25.21

u/l

0.05

313

Female infertility

396

0.78

0.96

1.3

1.1

21.16

19.72

u/l

0.08

368

Other benign neoplasms of skin

822

1.19

0.95

1.2

1.1

25.85

24.96

u/l

0.05

731

Adenocarcinoma and papilloma adenocarcinoma of rectum

141

1.49

0.94

1.0

1.1

27.19

25.21

u/l

0.07

124

Asthma, hospital admissions , main diagnosis only

222

1746

1.12

0.94

1.1

19.76

24.90

u/l

1.04

206

1570

Squamous cell neoplasms and carcinomas of the skin

117

1.54

0.93

1.2

1.1

28.46

29.11

u/l

0.03

100

Congenital malformations and deformations of the musculoskeletal system

149

1.47

0.93

1.0

1.1

16.73

20.90

u/l

0.26

140

Unspecified visual impairment (binocular)

2.15

0.91

1.0

1.1

25.67

30.71

u/l

—

Alzheimer disease, excluding more controls

239

0.72

0.90

1.0

1.1

39.85

21.38

u/l

0.75

207

Nasal polyp

360

0.72

0.89

1.0

1.1

26.02

30.66

u/l

0.15

327

Congenital malformations and deformations of the musculoskeletal system

118

1.52

0.88

1.1

18.28

23.34

u/l

0.25

110

Impotence

1.65

0.88

1.0

1.1

64.85

52.81

u/l

0.10

Malignant neoplasm of eye, brain and central nervous system

1.79

0.88

1.3

1.1

27.30

22.51

u/l

—

Maternal care for other known or suspected fetal problems

231

1.29

0.88

1.1

1.2

12.30

15.37

u/l

0.54

223

Glaucoma suspect

840

1.18

0.87

1.1

22.25

26.24

u/l

0.48

752

Disorders of tooth development and eruption

205

1.34

0.87

1.1

9.79

24.37

u/l

3.67

190

Necrosis of pulp, including avohilmo

149

1302

1.14

0.86

1.1

16.70

24.06

u/l

2.25

135

1186

Bacterial pneumoniae

716

1.18

0.86

1.2

1.1

20.54

23.08

u/l

0.32

629

Lumbar disc prolapse

172

1165

1.13

0.86

1.2

1.1

21.71

25.55

u/l

0.53

159

1051

Keratoconus

1.82

0.86

1.0

1.1

17.97

29.77

u/l

—

Other and unspecified tonsillitis

400

1.24

0.85

1.2

1.1

20.35

26.27

u/l

0.49

374

Dementia

717

0.84

0.83

1.1

25.21

27.89

u/l

0.24

624

Hallux valgus (acquired)

565

1.18

0.83

1.1

14.22

25.22

u/l

3.69

508

COPD, hospital admission 2, with asthma infections

581

1.20

0.83

1.2

1.1

23.87

30.35

u/l

0.77

510

Asthma and allergy, excluding more controls

152

1.43

0.83

1.3

1.1

37.42

14.68

u/l

0.54

139

Acne

121

1.49

0.82

1.6

1.1

11.28

18.71

u/l

1.27

115

Dementia, including avohilmo

766

0.85

0.81

1.1

25.13

27.15

u/l

0.18

667

Benign neoplasm: Skin of eyelid, including canthus

318

0.72

0.80

1.2

1.1

18.00

27.93

u/l

1.33

286

Crushing injury of wrist and hand

0.00

0.79

0.0

1.2

—

31.03

—

Iliotibial band syndrome

0.00

0.79

0.0

1.1

—

22.48

—

Coxibs

294

1.22

0.79

1.1

1.2

31.38

28.10

u/l

0.10

263

Noninflammatory disorders of female genital tract

109

469

1.17

0.79

1.1

18.33

21.19

u/l

0.36

430

Abnormal findings on diagnostic imaging of central nervous system

1.67

0.78

1.4

1.1

23.32

20.90

u/l

0.08

Chronic sinusitis

111

961

1.15

0.78

1.1

19.50

24.99

u/l

0.86

101

867

Dislocation, sprain and strain of joints and ligaments at neck level

225

1.33

0.77

1.0

1.1

18.80

19.01

u/l

0.01

215

Diseases of appendix

196

1588

1.11

0.77

1.2

1.1

15.02

24.80

u/l

6.17

176

1446

Delivery

523

0.85

0.76

1.1

1.2

17.43

26.11

u/l

1.34

468

Any dementia, excluding more controls

568

0.84

0.75

1.1

27.31

26.74

u/l

0.04

491

Preterm labour and delivery

595

1.19

0.75

1.1

16.18

18.84

u/l

0.36

546

Maternal care related to the fetus and amniotic cavity and possible delivery problems

643

0.86

0.75

1.1

1.2

15.86

18.01

u/l

0.26

595

Other disorders of thyroid

2.09

0.74

2.0

1.1

10.20

20.55

u/l

—

Hypersomnia

2.09

0.74

1.0

1.1

20.50

39.00

u/l

—

Acute alcohol intoxication

451

1.22

0.73

1.1

27.56

25.93

u/l

0.10

412

Other mycoses, not elsewhere classified/unspecified

2.01

0.73

1.0

1.1

8.80

26.55

u/l

—

Optic atrophy

2.01

0.73

1.4

1.1

9.40

38.35

u/l

—

Pleural plaque without asbestos

1.61

0.72

1.2

1.1

45.11

39.78

u/l

—

Unstable angina pectoris

623

1.17

0.72

1.1

25.28

25.41

u/l

0.01

538

Cysts of oral region, not elsewhere classified

1.52

0.72

1.3

1.1

10.69

25.92

u/l

2.69

COPD, hospital admissions 1, only main diagnosis

638

1.17

0.71

1.2

1.1

21.64

30.23

u/l

1.34

561

Care involving use of rehabilitation procedures

153

1256

1.12

0.70

1.2

1.1

26.56

20.55

u/l

1.14

132

1122

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

718

1.17

0.68

1.1

16.25

19.24

u/l

0.40

665

Optic atrophy

1.86

0.68

1.4

1.1

9.40

35.84

u/l

—

Pregnancy examination and test

164

0.72

0.68

1.2

15.64

13.98

u/l

0.11

153

Other lesions of median nerve

1.67

0.68

1.1

5.14

26.43

u/l

—

Asthma and allergy

159

1.37

0.67

1.3

1.1

37.42

16.34

u/l

0.49

145

Complications of labour and delivery

168

840

1.11

0.65

1.1

16.45

21.01

u/l

1.08

150

765

Chronic rhinitis, nasopharyngitis and pharyngitis

679

1.16

0.65

1.1

13.16

26.93

u/l

4.41

614

Radial styloid tenosynovitis [de Quervain]

1.48

0.64

1.1

27.70

24.41

u/l

0.11

Meniscus derangement

140

842

1.12

0.63

1.1

23.23

24.62

u/l

0.15

120

759

Pneumothorax

104

1.44

0.62

1.0

1.1

51.11

33.74

u/l

0.25

Acute bronchiolitis

1.64

0.62

1.0

1.2

32.13

14.33

u/l

—

Use of donepezil

375

0.79

0.62

1.0

1.1

30.65

u/l

0.00

324

Appendectomy

167

1446

1.10

0.62

1.2

1.1

16.85

24.31

u/l

1.76

149

1318

Anti-inflammatory and antirheumatic products, non-steroids

299

1.18

0.61

1.1

1.2

27.49

27.73

u/l

0.01

267

Abnormal findings in secretions and smears from cervix uteri vagina vulva

106

906

0.88

0.61

1.1

1.2

14.65

18.04

u/l

0.89

100

830

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.60

0.0

1.1

—

23.84

—

Other benign neoplasm of uterus: Corpus uteri

0.00

0.60

0.0

1.1

—

26.29

—

Malignant neoplasm of rectum

139

1.37

0.60

1.0

1.1

28.74

24.71

u/l

0.14

123

Ehlers-Danlos syndrome

0.00

0.59

0.0

1.2

—

27.18

—

Malignant neoplasm of mesothelium and soft tissue

1.51

0.58

1.1

60.75

30.62

u/l

—

Soft tissue disorders related to use, overuse and pressure

575

1.17

0.58

1.2

1.1

34.03

26.63

u/l

0.30

514

Multiple delivery

185

0.70

0.58

1.1

1.2

11.05

19.96

u/l

1.26

170

Childhood asthma (age<16), excluding more controls

103

1.38

0.58

1.1

15.33

9.59

u/l

0.43

Ingrowing nail

1.48

0.57

1.0

1.1

75.58

25.21

u/l

0.42

Lichen planus, including avohilmo

401

1.20

0.57

1.1

15.80

26.22

u/l

1.83

361

Benign neoplasm: Vulva

1.67

0.56

1.0

1.1

7.83

25.91

u/l

—

Aggressive periodontitis

1.67

0.56

1.3

1.1

9.67

30.19

u/l

—

Hemiplegia

1.51

0.56

1.0

1.1

10.91

26.42

u/l

1.90

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.46

0.56

1.1

39.88

32.78

u/l

—

Childhood asthma (age<16)

104

1.36

0.55

1.1

15.33

9.91

u/l

0.40

Atrophic disorders of skin

284

1.23

0.55

1.0

1.1

22.77

21.18

u/l

0.10

253

Lichen ruber planus, wide definition including periferal and oral lichen planus

486

1.17

0.54

1.1

17.15

25.50

u/l

1.49

439

Benign lipomatous neoplasm

665

0.86

0.54

1.1

14.85

26.28

u/l

2.11

600

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

155

1117

1.10

0.53

1.1

17.26

21.88

u/l

1.23

142

1016

Bacterial pneumonia (organism specified)

109

884

1.12

0.53

1.2

1.1

23.79

25.58

u/l

0.19

777

Melanocytic naevi of scalp and neck

1.54

0.53

1.2

1.1

21.67

35.66

u/l

—

Other noninflammatory disorders of vagina

134

1.35

0.53

1.0

1.1

12.33

18.75

u/l

0.82

125

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

553

1.16

0.52

1.2

1.1

32.63

27.86

u/l

0.17

499

Other and/or unspecified nontoxic goitre

158

0.70

0.52

1.0

1.1

19.72

22.33

u/l

0.17

142

Palmar fascial fibromatosis [Dupuytren]

286

1.22

0.52

1.1

20.87

31.69

u/l

1.10

251

Malignant neoplasm of brain, including Hilmo

1.43

0.52

1.3

1.1

36.11

22.25

u/l

—

Lateral epicondylitis

259

1.24

0.52

1.1

26.80

20.53

u/l

0.20

237

Enteropathic arthropathies

1.50

0.51

1.0

11.00

21.53

u/l

—

Pedal cyclist injured in transport accident

412

0.82

0.50

1.2

1.1

49.71

23.39

u/l

0.56

373

Appendicitis, broad definition

189

1579

1.08

0.49

1.2

1.1

14.87

24.82

u/l

6.23

169

1437

Medical abortion

175

872

1.09

0.49

1.2

1.1

21.81

20.51

u/l

0.17

161

791

Voice disturbances

595

1.14

0.48

1.1

16.53

24.98

u/l

1.45

535

Unspecified event, undetermined intent

1.49

0.47

1.0

1.1

16.93

29.40

u/l

—

Mumps

1.49

0.47

1.0

1.1

25.59

20.80

u/l

—

Subjective visual disturbances

526

1.14

0.43

1.2

1.1

15.38

25.51

u/l

2.20

475

Carcinoma in situ of skin of scalp and neck

1.62

0.43

1.0

1.1

39.20

46.50

u/l

—

Tularaemia

1.57

0.42

1.0

1.1

32.60

33.16

u/l

—

Acute appendicitis

176

1530

1.08

0.41

1.2

1.1

15.40

24.81

u/l

5.31

157

1394

Melanocytic naevi of eyelid, including canthus

0.00

0.41

0.0

1.1

—

27.01

—

Open bite that required surgery (Lefort1 or BSSO)

0.00

0.41

0.0

1.2

—

34.52

—

Heberden's nodes [with arthropathy]

0.00

0.41

0.0

1.1

—

23.05

—

Frostbite

0.00

0.41

0.0

1.1

—

40.42

—

Benign neoplasm: Scapula and long bones of upper limb

0.00

0.40

0.0

1.1

—

30.11

—

Other injuries of upper limb, level unspecified

0.00

0.40

0.0

1.1

—

38.16

—

Bruxism

1.47

0.40

1.0

1.1

6.20

26.80

u/l

—

Other superficial mycoses

1.47

0.40

1.0

1.1

102.00

26.79

u/l

—

Other specified/unspecified dorsopathies

1.34

0.40

1.0

1.2

29.50

23.91

u/l

—

Ehlers-Danlos syndrome

0.00

0.40

0.0

1.2

—

31.28

—

Use of rotigotine

0.00

0.40

0.0

1.1

—

42.83

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

0.40

0.0

1.0

—

29.59

—

Complications associated with artificial fertilization

0.00

0.40

0.0

1.1

—

15.78

—

Crowding of teeth, including avohilmo

0.68

0.40

1.1

8.29

20.42

u/l

—

Injury of nerves at lower leg level

0.00

0.39

0.0

1.1

—

39.41

—

Intracranial and intraspinal abscess and granuloma

0.00

0.39

0.0

1.1

—

20.67

—

Fasciculation

0.00

0.39

0.0

1.1

—

34.88

—

Use of cabergoline

0.00

0.39

0.0

1.1

—

35.93

—

Inguinal hernia

112

817

0.92

0.39

1.1

33.82

28.03

u/l

0.36

100

726

Dementia in Alzheimer disease

274

0.83

0.39

1.0

1.1

51.09

31.49

u/l

0.56

243

Other epidermal thickening

1.37

0.38

1.3

1.1

14.33

25.05

u/l

—

Injury of intra-abdominal organs

1.39

0.38

1.2

1.0

11.08

25.30

u/l

—

Thiazolidinediones

206

1.21

0.37

1.0

1.1

36.55

25.21

u/l

0.53

187

Childhood allergy (age < 16)

110

1.27

0.37

1.4

1.2

12.00

10.57

u/l

0.10

100

Other maternal disorders predominantly related to pregnancy

134

905

0.93

0.35

1.2

1.1

18.42

19.87

u/l

0.16

117

835

Melanocytic naevi of upper limb, including shoulder

1.34

0.33

1.0

1.1

34.32

28.34

u/l

—

Vascular dementia (subcortical)

1.31

0.33

1.0

1.1

21.00

45.93

u/l

—

Brain meningioma

0.70

0.33

1.0

1.1

47.17

20.14

u/l

—

Endometriosis ASRM stages 3,4

483

1.12

0.32

1.1

1.2

30.29

19.42

u/l

0.65

438

Maternal care for known or suspected abnormality of pelvic organs

317

0.88

0.31

1.2

9.17

17.19

u/l

4.12

303

Disorder of external ear, unspecified

1.32

0.31

1.1

1.2

44.79

29.88

u/l

—

Vascular dementia

142

1.22

0.30

1.1

27.62

35.19

u/l

0.42

129

malignant neoplasm of female genital organs

285

1.15

0.30

1.2

1.1

22.90

18.67

u/l

0.29

241

Mouth breathing

849

1.08

0.30

1.1

15.48

27.68

u/l

3.82

771

Glaucoma, exfoliation

203

1.18

0.29

1.3

1.1

14.27

32.18

u/l

2.57

182

Disturbance of activity and attention

118

1.25

0.29

1.4

1.1

6.69

15.53

u/l

2.31

111

Ectopic pregnancy

408

0.88

0.28

1.1

26.78

18.79

u/l

0.40

379

Asthma and opportunity respiratory infection

1.32

0.28

1.0

1.1

44.40

27.63

u/l

—

Examination and encounter for administrative purposes

1.25

0.27

1.1

37.63

33.74

u/l

—

Injury of muscle and tendon at lower leg level

252

1.15

0.27

1.2

1.1

26.08

28.67

u/l

0.12

233

Benign neoplasm of mouth and pharynx

197

1.17

0.25

1.1

29.43

24.91

u/l

0.19

180

Other neurotic disorders

1.25

0.25

1.2

1.1

27.89

25.68

u/l

—

Other noninflammatory disorders of uterus, except cervix

363

1.10

0.25

1.2

1.1

24.06

24.14

u/l

0.00

328

Acute appendicitis, no complications

133

1251

1.06

0.25

1.2

1.1

16.35

24.98

u/l

3.41

119

1146

Triptan medication for migraine, min. 3 purchases

125

1010

0.94

0.24

1.2

1.1

18.13

19.22

u/l

0.12

120

930

Other aneurysm

1.17

0.24

1.7

1.1

42.11

32.79

u/l

—

Acute appendicitis, with complications

388

1.11

0.24

1.1

12.39

27.92

u/l

4.19

355

Primary angle-closure glaucoma

0.70

0.24

1.2

1.1

16.17

22.88

u/l

—

Erythema multiforme

1.32

0.23

1.2

1.1

8.00

34.55

u/l

—

Bacterial pneumonia, not elsewhere classified

682

1.07

0.23

1.1

20.16

23.26

u/l

0.36

598

Persons encountering health services in circumstances related to reproduction

127

903

0.95

0.22

1.1

19.04

23.87

u/l

0.83

119

830

Other abnormal products of conception

455

1.08

0.22

1.1

17.52

16.61

u/l

0.08

430

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.22

0.22

1.0

1.1

82.80

21.43

u/l

—

Malignant neoplasm of other and unspecified parts of mouth

0.00

0.21

0.0

1.1

—

51.87

—

Implicit parasitic Sepsis

0.00

0.21

0.0

1.1

—

31.52

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.21

0.0

1.2

—

42.71

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.21

0.0

1.2

—

53.73

—

Accessory breast

0.00

0.21

0.0

1.1

—

28.11

—

Injury of blood vessels at wrist and hand level

0.00

0.21

0.0

1.1

—

54.88

—

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

0.00

0.21

0.0

1.2

—

51.57

—

Lesion of femoral nerve

0.00

0.21

0.0

1.1

—

27.37

—

Other bursitis of elbow

0.00

0.21

0.0

1.4

—

47.07

—

Conotruncal defects

0.00

0.21

0.0

1.2

—

9.06

—

Malignant neoplasm of base of tongue

0.00

0.21

0.0

1.3

—

41.14

—

Malignant neoplasm of palate, including Hilmo

0.00

0.21

0.0

1.2

—

27.39

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.21

0.0

1.3

—

30.42

—

Amoebiasis

0.00

0.21

0.0

1.2

—

26.89

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

0.21

0.0

1.1

—

48.39

—

Unequal limb length (acquired)

0.00

0.21

0.0

1.0

—

32.93

—

Coarctation of the aorta

0.00

0.21

0.0

1.1

—

32.56

—

Gender identity disorders

0.00

0.21

0.0

1.0

—

25.25

—

Transient global amnesia

188

0.85

0.21

1.1

18.56

26.21

u/l

0.68

168

Contact with sharp object, undetermined intent

1.16

0.21

1.2

1.1

18.40

28.83

u/l

—

Motorcycle rider injured in noncollision transport accidents

1.16

0.21

1.0

1.2

6.22

28.34

u/l

—

Right side

0.00

0.21

0.0

1.2

—

41.59

—

Hyperprolactinaemia, drug-induced

0.00

0.21

0.0

1.3

—

19.85

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.1

—

10.08

—

Malignant neoplasm of base of tongue, including Hilmo

0.00

0.21

0.0

1.2

—

39.52

—

Other and unspecified pemphigoid

0.00

0.21

0.0

1.2

—

49.31

—

Urticaria due to cold and heat

0.00

0.21

0.0

1.1

—

23.85

—

Endometriosis diagnosis and infertility diagnosis occurring together

177

0.85

0.21

1.1

9.40

16.58

u/l

2.14

167

Unspecified maternal hypertension

0.00

0.21

0.0

1.2

—

37.55

—

Injury of nerves at ankle and foot level

0.00

0.20

0.0

1.1

—

37.29

—

Cicatricial alopecia [scarring hair loss]

0.00

0.20

0.0

1.1

—

17.22

—

Liposarcoma, including Hilmo

0.00

0.20

0.0

1.1

—

38.49

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

259

1.09

0.19

1.1

36.04

31.02

u/l

0.18

228

Gestational diabetes (for exclusion)

484

0.93

0.19

1.1

1.2

10.36

16.35

u/l

2.80

454

Nonspecific lymphadenitis

109

1.19

0.18

1.1

22.05

22.01

u/l

0.00

104

Other peripheral vascular diseases

128

1.17

0.18

1.1

11.80

23.96

u/l

1.45

117

Bacterial meningitis

1.21

0.18

1.1

9.70

27.67

u/l

—

Other and unspecified effects of external causes

518

0.93

0.18

1.1

44.08

22.28

u/l

0.61

473

Redundant prepuce, phimosis and paraphimosis

297

1.10

0.17

1.1

23.80

37.96

u/l

1.06

267

Other and unspecified abdominal hernia

1.15

0.17

1.0

1.1

10.00

24.40

u/l

—

Cyst of kidney

110

1.18

0.17

1.1

17.06

33.71

u/l

1.26

Alzheimer’s disease (Early onset)

0.75

0.17

1.0

1.1

30.80

27.19

u/l

—

Multiple gestation

152

0.85

0.16

1.2

13.05

16.75

u/l

0.39

147

Non-small cell lung cancer, squamous, helper endpoint

0.71

0.16

1.4

1.1

11.60

33.39

u/l

—

Other vitreous opacities

1.18

0.16

1.0

1.1

10.75

26.22

u/l

—

Other diseases of gallbladder

1.18

0.16

1.3

1.2

22.50

25.63

u/l

—

Glucosamine medication

128

980

1.04

0.16

1.1

30.05

27.49

u/l

0.20

115

865

Other and unspecified iridocyclitis

1.10

0.15

1.1

19.13

26.36

u/l

—

Vascular syndromes of brain in cerebrovascular disorders

1.14

0.15

1.2

1.1

17.78

30.62

u/l

—

Other degenerative diseases of the nervous system

422

0.94

0.15

1.1

29.11

21.61

u/l

0.59

377

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

102

1.18

0.15

1.3

1.1

29.43

23.71

u/l

—

Brain meningioma, including Hilmo

0.79

0.14

1.0

1.1

191.43

19.85

u/l

—

Superficial injury of head

442

1.06

0.13

1.1

35.67

23.22

u/l

0.31

400

Diabetes mellitus in pregnancy

383

1.05

0.12

1.2

1.1

16.39

15.40

u/l

0.10

365

Postpartum haemorrhage due to retained placenta

199

0.90

0.11

1.1

17.46

14.81

u/l

0.10

191

Pregnancy with abortive outcome

173

878

1.03

0.11

1.2

1.1

19.57

20.52

u/l

0.13

158

795

Dislocation, sprain and strain of joints and ligaments of knee

132

1253

0.97

0.11

1.1

16.11

23.20

u/l

2.22

124

1144

Brachial plexus disorders

157

0.89

0.11

1.1

21.60

19.56

u/l

0.11

150

Hyperkinetic disorders

131

1.12

0.11

1.4

1.1

6.69

15.87

u/l

2.68

124

Abrasion of teeth

779

1.04

0.11

1.2

1.1

21.45

23.36

u/l

0.19

709

Injury of muscle and tendon at shoulder and upper arm level

760

0.96

0.10

1.1

20.13

27.94

u/l

0.67

680

Cervicobrachial syndrome

495

0.95

0.10

1.1

13.72

24.70

u/l

3.38

447

Chronic diseases of tonsils and adenoids

192

1185

1.02

0.10

1.2

1.1

14.90

25.40

u/l

5.26

180

1082

Twin gestation

144

0.90

0.08

1.2

13.05

17.23

u/l

0.45

139

Benign neoplasm: Skin of ear and external auricular canal

1.08

0.08

1.0

1.2

106.71

31.86

u/l

—

Femoral hernia

0.84

0.07

1.2

1.1

14.83

28.49

u/l

—

Endometriosis

454

0.97

0.07

1.1

29.43

21.49

u/l

0.57

416

Inflammatory diseases of the central nervous system

137

1.10

0.07

1.1

10.21

25.88

u/l

3.50

126

Meningitis

0.82

0.07

1.1

9.70

25.42

u/l

—

Spermatocele

118

1.10

0.07

1.2

1.1

16.38

41.65

u/l

1.22

106

Other menopausal disorders

389

0.97

0.06

1.2

1.1

18.18

21.79

u/l

0.21

355

Organic, including symptomatic, mental disorders

123

858

1.02

0.06

1.1

23.90

27.32

u/l

0.42

102

756

Benign neoplasm of ovary

405

1.04

0.05

1.2

1.1

23.40

19.80

u/l

0.19

358

Radiculopathy

333

0.96

0.05

1.1

19.69

27.82

u/l

0.53

297

Crushed, pushed or stepped on by crowd or human stampede

101

1.09

0.04

1.0

1.1

23.38

22.56

u/l

0.02

Early lumbar disc prolapse, operated

131

1.07

0.03

1.1

12.68

21.28

u/l

0.67

126

Inflammatory disease of uterus

250

0.96

0.03

1.2

22.95

17.36

u/l

0.30

232

Sequelae of injuries of upper limb

172

1.05

0.02

1.0

1.1

17.03

22.37

u/l

0.60

163

Divergent concomitant strabismus

123

1.06

0.01

1.2

1.1

14.45

22.74

u/l

0.99

116

Later onset COPD

480

1.01

0.01

1.2

1.1

21.00

31.50

u/l

1.51

414

Acute nasopharyngitis (common cold)

165

0.96

0.01

1.1

19.49

30.32

u/l

0.80

153

Spontaneous abortion

110

745

1.00

0.00

1.1

21.86

19.91

u/l

0.22

101

685

Viral haemorrhagic fevers, not elsewhere classified/unspecified

125

0.96

0.00

1.2

1.1

38.17

26.20

u/l

0.33

115

Ocular pain

145

1.03

0.00

1.3

1.1

18.31

22.16

u/l

0.30

136

Adverse effects, not elsewhere classified

365

0.99

0.00

1.1

26.66

19.06

u/l

0.39

334

Contraceptive management

661

1.00

0.00

1.2

1.1

15.06

22.36

u/l

1.60

611

Melanocytic naevi of other and unspecified parts of face

1.04

0.00

1.3

1.1

39.50

23.26

u/l

—

Additional codes for the location of defect, injury or illness

1.04

0.00

1.0

1.1

71.44

24.51

u/l

—

Chronic suppurative otitis media

104

0.96

0.00

1.1

89.10

23.02

u/l

—

Other disorders of eye and adnexa

255

1.02

0.00

1.2

1.1

20.70

20.82

u/l

0.01

232

Chronic suppurative otitis media, including avohilmo

122

0.98

0.00

1.1

75.58

22.58

u/l

0.45

109

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.0

1.1

—

35.75

—

Other primary thrombocytopenia

0.00

0.0

1.2

—

25.20

—

Endometriosis of fallopian tube

0.00

0.0

1.1

—

22.13

—

Malignant neoplasm of renal pelvis

0.00

0.0

1.3

—

63.50

—

Other and unspecified atrophic disorders of skin

0.00

0.0

1.1

—

14.13

—

Contact with blunt object, undetermined intent

0.00

0.0

1.1

—

34.21

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

0.0

1.3

—

20.14

—

Other and unspecified injuries of forearm

0.00

0.0

1.1

—

21.97

—

Liposarcoma

0.00

0.0

1.3

—

37.88

—

Collapsed vertebra, not elsewhere classified

0.00

0.0

1.2

—

28.11

—

Acne keloid

0.00

0.0

1.2

—

26.17

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.2

—

34.60

—

Frontotemporal dementia

0.00

0.0

1.1

—

65.00

—

Toxic effect of other noxious substances eaten as food

0.00

0.0

1.2

—

21.14

—

Unspecified parasitic disease

0.00

0.0

1.1

—

42.44

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.2

—

4.14

—

Other specified acquired deformities of limbs

0.00

0.0

1.0

—

7.40

—

Other congenital malformations of nervous system

0.00

0.0

1.1

—

30.22

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.2

—

61.40

—

Discontinuity and dislocation of ear ossicles

0.00

0.0

1.1

—

43.00

—

Defect, injury or illness of neck

0.00

0.0

1.2

—

9.17

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.3

—

18.62

—

Other and unspecified spinal muscular atrophies

0.00

0.0

1.2

—

53.00

—

Malignant neoplasm of nasal cavity and middle ear

0.00

0.0

1.2

—

56.86

—

Magnesium deficiency

0.00

0.0

1.4

—

10.20

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.0

1.1

—

25.84

—

Benign neoplasm: Eye, unspecified

0.00

0.0

1.1

—

20.96

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.2

—

25.40

—

Other and unspecified parapsoriasis

0.00

0.0

1.2

—

25.20

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.0

1.1

—

21.00

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

0.0

1.2

—

20.83

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

1.0

—

4.94

—

Tetralogy of Fallot, a congenital heart defect.

0.00

-0.00

0.0

1.2

—

13.12

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.2

—

86.33

—

Congenital varicose veins

0.00

-0.00

0.0

1.2

—

8.33

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.2

—

25.83

—

Ectopic testis

0.00

-0.00

0.0

1.0

—

2.74

—

Arnold-Chiari syndrome

0.00

-0.00

0.0

1.1

—

30.22

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.2

—

40.00

—

Osteomalacia

0.00

-0.00

0.0

1.0

—

12.34

—

Abscess of tendon sheath

0.00

-0.00

0.0

1.1

—

60.63

—

Lichen planopilaris

0.00

-0.00

0.0

1.4

—

10.80

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.0

—

4.43

—

Apocrine sweat disorders, other sweat gland disorders

0.00

-0.00

0.0

1.3

—

24.00

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.2

—

15.80

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.2

—

21.95

—

Chylothorax

0.00

-0.00

0.0

1.2

—

18.94

—

Complications following myocardial infarction

0.00

-0.00

0.0

1.2

—

64.00

—

Transient retinal artery occlusion

0.00

-0.00

0.0

1.4

—

46.20

—

Ovarian dysfunction, other/unspecified

0.00

-0.00

0.0

1.2

—

30.44

—

Meningitis, viral

0.00

-0.00

0.0

1.1

—

11.43

—

Lesion of medial popliteal nerve

0.00

-0.00

0.0

1.1

—

32.86

—

Femoral hernia, bilateral

0.00

-0.00

0.0

1.3

—

48.14

—

Constitutional tall stature

0.00

-0.00

0.0

1.0

—

4.40

—

Thiamine deficiency

0.00

-0.00

0.0

1.1

—

34.57

—

Histrionic personality disorder

0.00

-0.00

0.0

1.3

—

32.00

—

Sleepwalking [somnambulism]

0.00

-0.00

0.0

1.2

—

17.95

—

Disorders of adrenal gland, other and/or unspecified

0.00

-0.00

0.0

1.0

—

33.40

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.2

—

58.14

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.4

—

25.00

—

Disorders of pituitary gland, other and/or unspecified

0.00

-0.00

0.0

1.2

—

6.45

—

Benign neoplasm: Carotid body

0.00

-0.00

0.0

1.2

—

12.62

—

Benign neoplasm of other and unspecified female genital organs

0.94

-0.00

1.0

1.1

9.00

22.01

u/l

—

Benign neoplasm: Lower jaw bone

0.00

-0.00

0.0

1.2

—

25.20

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

-0.00

0.0

1.0

—

74.95

—

Mucinous and mucinous cystic tumor

0.00

-0.00

0.0

1.3

—

14.00

—

Malignant neoplasm of hypopharynx

0.00

-0.00

0.0

1.0

—

74.95

—

Chromophobe cell carcinoma of kidney

0.00

-0.00

0.0

1.2

—

39.45

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

46.62

—

Chondrosarcoma, including Hilmo

0.00

-0.00

0.0

1.2

—

47.45

—

Malignant neoplasm of gallbladder

0.00

-0.00

0.0

1.4

—

30.34

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

-0.00

0.0

1.2

—

23.30

—

Malignant neoplasm of gum

0.00

-0.00

0.0

1.1

—

42.81

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.0

—

21.81

—

Schistosomiasis [bilharziasis]

0.00

-0.00

0.0

1.2

—

21.60

—

Other cestode infections

0.00

-0.00

0.0

1.4

—

25.00

—

Implicit parasitic Sepsis

0.00

-0.00

0.0

1.0

—

46.81

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.2

—

7.14

—

Amoebiasis

0.00

-0.00

0.0

1.3

—

39.12

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

1.3

—

66.71

—

Rhinophyma

0.00

-0.00

0.0

1.1

—

85.29

—

Mucinous and mucinous cystic tumor, including Hilmo

0.00

-0.00

0.0

1.2

—

12.78

—

Prominent ears

0.00

-0.00

0.0

1.0

—

5.71

—

Congenital hydrocephalus

0.00

-0.00

0.0

1.2

—

23.45

—

Non-small cell lung cancer, squamous

0.89

-0.00

1.4

1.1

11.60

31.41

u/l

—

Congenital malformations of oesophagus

0.00

-0.00

0.0

1.2

—

87.60

—

Blindness or visual impairment, binocular

0.00

-0.00

0.0

1.2

—

24.94

—

Cardiomyopathies, Secondary/extrinsic

0.00

-0.00

0.0

1.0

—

40.21

—

Hereditary motor and sensory neuropathy

0.00

-0.00

0.0

1.1

—

34.59

—

Carcinoma in situ of endometrium

0.00

-0.00

0.0

1.2

—

20.34

—

Separation of retinal layers (serosa)

0.98

-0.00

1.0

1.1

22.33

25.19

u/l

—

Other mosquito-borne viral fevers

0.00

-0.00

0.0

1.1

—

15.52

—

Restrictive cardiomyopathy

0.00

-0.00

0.0

1.2

—

51.78

—

Changes in corneal membranes

0.00

-0.00

0.0

1.0

—

23.76

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.2

—

22.00

—

Other and unspecified pemphigus

0.00

-0.00

0.0

1.2

—

46.14

—

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

12.00

—

Muscular dystrophy

0.00

-0.00

0.0

1.2

—

9.63

—

Reiter disease

0.00

-0.00

0.0

1.1

—

23.81

—

Other congenital malformations, not elsewhere classified

0.00

-0.00

0.0

1.0

—

19.74

—

Drowning and submersion while in natural water

0.00

-0.00

0.0

1.2

—

77.17

—

Female infertility, uterine origin

0.00

-0.00

0.0

1.0

—

6.33

—

0.00

-0.00

0.0

1.1

—

39.08

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS